About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
2915 genotypes with 5458 annotations displayed of selected term and subterms
Searched Term: liver/biliary system phenotype
Allelic Composition
(Genetic Background)
Annotated Term Reference
1700007K13RikGt(OST3440)Lex/1700007K13RikGt(OST3440)Lex
(either: (involves: 129S5/SvEvBrd * C57BL/6J) or (involves: 129S5/SvEvBrd * C57BL/6J * FVB/N))
abnormal liver lobule morphology J:252050
4930412L05Riktm1.1Pton/4930412L05Riktm1.1Pton
(B6.Cg-4930412L05Riktm1.1Pton)
hepatic steatosis J:233670
increased liver cholesterol level J:233670
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
enlarged liver sinusoidal spaces J:239583
herniated liver J:239583
a/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+

(involves: C57BL/6 * KK)
decreased liver weight J:168271
Ay/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+

(involves: C57BL/6 * KK)
decreased liver weight J:168271
Ay/A
(involves: C57BL/6)
increased liver weight J:131039
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
hepatic steatosis J:64390
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
abnormal liver physiology J:99152
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
abnormal liver morphology J:99152
Abcb1atm1Bor/Abcb1atm1Bor
Npc1m1N/Npc1m1N

(involves: 129/Ola * BALB/c)
increased liver cholesterol level J:76395
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))
abnormal bile canaliculus morphology J:21232, J:15531
abnormal bile composition J:15531
abnormal bile duct morphology J:15531
abnormal bile secretion J:15531
abnormal hepatobiliary system morphology J:21232
abnormal hepatobiliary system physiology J:21232
abnormal hepatocyte morphology J:15531
abnormal portal triad morphology J:21232
bile duct inflammation J:21232, J:15531
bile duct proliferation J:21232
biliary cirrhosis J:21232
cholestasis J:21232
dilated bile duct J:15531
enlarged liver J:21232
hepatic necrosis J:21232
increased hepatocellular carcinoma incidence J:21232
intrahepatic cholestasis J:15531
liver hemorrhage J:21232
liver inflammation J:15531
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N)
abnormal hepatocyte morphology J:175015
bile duct inflammation J:175015
focal hepatic necrosis J:175015
intrahepatic cholestasis J:175015
liver inflammation J:175015
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
abnormal bile composition J:105357, J:100491
abnormal bile duct morphology J:105357
abnormal gallbladder size J:105357
abnormal liver morphology J:105357
bile duct inflammation J:105357
dilated bile duct J:105357
enlarged liver J:105357
gallstones J:105357
increased hepatocellular carcinoma incidence J:217802
intrahepatic cholestasis J:105357
liver cirrhosis J:217802
liver fibrosis J:217802
portal hypertension J:217802
Abcb4tm1Bor/Abcb4tm1Bor
(C.129P2-Abcb4tm1Bor)
liver fibrosis J:199949
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * BALB/c)
bile duct inflammation J:168123
liver fibrosis J:168123
Abcb4tm1Bor/Abcb4tm1Bor
(CAnNCrl.12P2(FVB)-Abcb4tm1Bor)
increased hepatocellular carcinoma incidence J:217802
liver cirrhosis J:217802
liver fibrosis J:217802
portal hypertension J:217802
Abcb4tm1Bor/Abcb4tm1Bor
Pemttm1J/Pemttm1J

(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
liver/biliary system phenotype J:175015
Abcb4tm1Bor/Abcb4tm1Bor
Portm1Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N)
bile duct proliferation J:215915
cholestasis J:215915
increased hepatocyte proliferation J:215915
increased liver weight J:215915
liver fibrosis J:215915
Abcb4tm1Bor/Abcb4tm1Bor
Tg(ABCG5/ABCG8)14-2Hobb/0

(involves: 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
abnormal bile composition J:100491
Abcb7tm1Mdf/Y
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(either: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA))
abnormal hepatocyte morphology J:106838
abnormal liver morphology J:106838
Abcb10tm1.2Tafu/Abcb10tm1.2Tafu
(involves: C57BL/6NCrlj * CBA/JNCrlj)
abnormal hepatocyte morphology J:223428
abnormal liver morphology J:223428
abnormal liver physiology J:223428
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal bile canaliculus morphology J:67548
abnormal bile secretion J:67548
abnormal hepatocyte morphology J:67548
enlarged liver J:67548
intrahepatic cholestasis J:67548
Abcc2tm1Ahs/Abcc2tm1Ahs
(involves: 129P2/OlaHsd * FVB)
abnormal bile secretion J:107822
abnormal liver physiology J:107822
increased liver weight J:107822
Abcc2tm1Dgen/Abcc2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
abnormal bile composition J:134950
abnormal bile secretion J:134950
abnormal liver physiology J:134950
Abcc3tm1Kruh/Abcc3tm1Kruh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
liver/biliary system phenotype J:114229
Abcd3tm1Safe/Abcd3tm1Safe
(involves: 129S4/SvJae * C57BL/6J)
abnormal bile composition J:217065
enlarged liver J:217065
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6)
decreased susceptibility to hepatic steatosis J:122438
Abcg1tm1Dgen/Abcg1tm1Dgen
(B6.129P2-Abcg1tm1Dgen)
hepatic steatosis J:117028
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB)
abnormal hepatocyte morphology J:201884
decreased liver glycogen level J:201884
liver inflammation J:201884
Abcg2tm1Ahs/Abcg2tm1Ahs
(either: (involves: 129P2/OlaHsd * FVB) or (involves: FVB))
abnormal bile color J:80519
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal liver physiology J:87209
enlarged liver J:87209
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd)
abnormal bile secretion J:112995
abnormal liver physiology J:112995
increased liver weight J:112995
Abcg8tm1Elk/Abcg8+
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal hepatobiliary system physiology J:94759
Abcg8tm1Elk/Abcg8tm1Elk
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal hepatobiliary system physiology J:94759
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA)
abnormal hepatocyte morphology J:199570
abnormal liver morphology J:199570
abnormal liver physiology J:199570
enlarged liver J:199570
hepatic steatosis J:199570
increased liver cholesterol level J:199570
increased liver free fatty acids level J:199570
increased liver triglyceride level J:199570
increased liver weight J:199570
liver fibrosis J:199570
liver inflammation J:199570
pale liver J:199570
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6)
hepatic steatosis J:160725
increased liver triglyceride level J:160725
Abhd5tm1Rze/Abhd5tm1Rze
Tg(Ckmm-cre)5Khn/0

(involves: 129P2/OlaHsd * C57BL/6 * FVB)
decreased liver triglyceride level J:197835
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
abnormal liver morphology J:234876
decreased liver triglyceride level J:234876
decreased liver weight J:234876
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J)
abnormal hepatocyte morphology J:72875
abn/abn
(STOCK tlow)
enlarged liver J:28671
Acacatm1Jkus/Acacatm1Jkus
Tg(Fabp1-cre)1Mmt/0

(involves: 129X1/SvJ * C57BL/6J * SJL)
decreased liver triglyceride level J:118861
Acacatm2Sjw/Acacatm2Sjw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S7/SvEvBrd * C57BL/6J * FVB)
abnormal liver physiology J:110200
decreased liver triglyceride level J:110200
decreased susceptibility to hepatic steatosis J:110200
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified)
decreased liver glycogen level J:68427
decreased liver triglyceride level J:68427
Acad8m1Ytc/Acad8m1Ytc
(involves: C57BL/6)
abnormal hepatocyte morphology J:222356
hepatic steatosis J:222356
Acadltm1Uab/Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac)
abnormal bile composition J:51660
hepatic steatosis J:72193, J:51660
Acadmtm1Uab/Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6)
hepatic steatosis J:115759
Acadsdel-J/Acadsdel-J
(involves: BALB/cByJ)
hepatic steatosis J:14707
Acadvltm1Uab/Acadvltm1Uab
(involves: 129S6/SvEvTac * C57BL/6)
hepatic steatosis J:72193
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6)
hepatic steatosis J:106714
Acancmd/Acancmd
(STOCK T tlow Itpr3tf)
abnormal liver morphology J:5952
enlarged liver J:5952
Acetm3Keb/Acetm3Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
liver/biliary system phenotype J:83178
Acot7tm1.1Mwol/Acot7tm1.1Mwol
Tg(Nes-cre)1Kln/0

(involves: C57BL/6 * SJL)
hepatic steatosis J:203753
increased liver triglyceride level J:203753
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6)
decreased susceptibility to hepatic steatosis J:182660
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6)
decreased liver cholesterol level J:183258
decreased liver triglyceride level J:183258
decreased susceptibility to hepatic steatosis J:183258
Acox1lampe1/Acox1lampe1
(involves: C57BL/6J)
abnormal hepatocyte morphology J:174942
abnormal liver morphology J:174942
enlarged liver J:174942
hepatic steatosis J:174942
increased hepatocellular carcinoma incidence J:174942
liver inflammation J:174942
Acox1tm1Jkr/Acox1+
(involves: 129P2/OlaHsd * C57BL/6J)
hepatic steatosis J:35794
Acox1tm1Jkr/Acox1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal liver physiology J:35794
abnormal liver regeneration J:48180
hepatic steatosis J:48180
increased hepatocellular carcinoma incidence J:35794
increased hepatoma incidence J:48180
increased liver weight J:35794
pale liver J:35794
Acta1tm1Jll/Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss)
decreased liver glycogen level J:78070
Actbtm1(Tag)Arge/Actb+
Tg(Hsp70-1-cre)1Arge/0

(involves: 129S1/Sv * C57BL/6J * CBA)
enlarged gallbladder J:87544
Actn4tm1a(EUCOMM)Wtsi/Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi)
biliary cyst J:239583
enlarged liver sinusoidal spaces J:239583
Acvr2btm1Enl/Acvr2btm1Enl
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6J))
abnormal liver morphology J:42018
Acvrl1tm1Enl/Acvrl1+
(involves: C57BL/6)
abnormal hepatobiliary system morphology J:82115
enlarged liver J:82115
enlarged liver sinusoidal spaces J:82115
Ad/Ad
(involves: Chr 7 marker stock * Wild stock)
abnormal liver morphology J:6095
Ad/Ad+
(involves: Chr 7 marker stock * Wild stock)
abnormal liver morphology J:6095
Adatm1Mw/Adatm1Mw
(involves: 129S7/SvEvBrd * C57BL/6)
abnormal hepatocyte morphology J:25085
abnormal liver morphology J:25085
decreased hepatocyte number J:25085
hepatic necrosis J:25085
increased hepatocyte karyomegaly J:25085
small liver J:25085
Adatm1Vlr/Adatm1Vlr
(either: 129P2/OlaHsd-Adatm1Vlr or (involves: (129P2/OlaHsd * FVB/N))
hepatic necrosis J:26731
intrahepatic cholestasis J:26731
Adamts3tm1.2Itl/Adamts3tm1.2Itl
(involves: BALB/cJ * C57BL/6NTac * SJL)
increased hepatocyte apoptosis J:245044
liver degeneration J:245044
small liver J:245044
Adamts3tm1b(KOMP)Wtsi/Adamts3tm1b(KOMP)Wtsi
(C57BL/6N-Adamts3tm1b(KOMP)Wtsi/Wtsi)
abnormal liver parenchyma morphology J:239583
Adamts7tm1a(KOMP)Wtsi/Adamts7tm1a(KOMP)Wtsi
(C57BL/6-Adamts7tm1a(KOMP)Wtsi)
abnormal oval cell physiology J:221183
decreased hepatocyte proliferation J:221183
Adartm1.1Knk/Adartm1.1Knk
(involves: 129S1/Sv * 129X1/SvJ)
increased hepatocyte apoptosis J:87714
Adartm1.1Phs/Adartm2Phs
Tg(Mx1-cre)1Cgn/?

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
liver hypoplasia J:142338
Adartm1Knk/Adartm1Knk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
abnormal liver morphology J:87714
increased hepatocyte apoptosis J:87714
Adartm1Phs/Adartm1Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal liver development J:87715
small liver J:87715
Adartm1Phs/Adartm1Phs
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
abnormal liver development J:87715
small liver J:87715
Adartm2Knk/Adar+
(chimera involves: 129S1/Sv * 129X1/SvJ * FVB/N)
abnormal liver development J:65981
Adartm2Phs/Adartm2Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal liver development J:87715
small liver J:87715
Adartm2Phs/Adartm2Phs
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
abnormal liver development J:87715
small liver J:87715
Adcy3Jll/Adcy3+
(C57BL/6J-Adcy3Jll)
decreased susceptibility to hepatic steatosis J:223554
Adcy9tm1b(EUCOMM)Wtsi/Adcy9tm1b(EUCOMM)Wtsi
(C57BL/6N-Adcy9tm1b(EUCOMM)Wtsi/Wtsi)
enlarged liver sinusoidal spaces J:239583
liver hemorrhage J:239583
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6))
hepatic steatosis J:71968
Add2tm1Llp/Add2tm1Llp
(involves: 129S4/SvJae * C57BL/6J)
increased liver iron level J:71029
Adip1LG/J/?
Capn10tm1Chev/Capn10+

((B6.129-Capn10tm1Chev x LG/J)F1)
increased liver weight J:153477
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J)
hepatic steatosis J:111346
increased liver triglyceride level J:111346
Adipoqtm1Far/Adipoqtm1Far
Dgat1tm1Far/Dgat1tm1Far

(involves: 129S4/SvJae * C57BL/6J)
decreased liver cholesterol level J:111346
decreased liver triglyceride level J:111346
decreased susceptibility to hepatic steatosis J:111346
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
liver/biliary system phenotype J:199264
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc)
increased liver triglyceride level J:122027
Adipor1tm1Tka/Adipor1tm1Tka
Adipor2tm1Tka/Adipor2tm1Tka

(involves: 129S4/SvJae * C57BL/6)
increased liver triglyceride level J:117919
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen)
decreased liver triglyceride level J:122027
Adktm1Bois/Adktm1Bois
(involves: 129P3/JEmsJ * C57BL/6)
hepatic steatosis J:81518
pale liver J:81518
Admtm1Hku/Admtm1Hku
(involves: 129S6/SvEvTac * C57BL/6)
abnormal liver vasculature morphology J:89608
liver hemorrhage J:89608
Adnp2em3(IMPC)Tcp/Adnp2em3(IMPC)Tcp
(C57BL/6NCrl-Adnp2em3(IMPC)Tcp/Tcp)
abnormal liver morphology J:211773
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J)
increased liver glycogen level J:87718
Aebp1tm1Mdl/Aebp1tm1Mdl
(involves: 129S2/SvPas * C57BL/6)
abnormal liver morphology J:70416
Afg3l2Emv66/Afg3l2Emv66
(FVB.MEV2-Afg3l2Emv66)
liver/biliary system phenotype J:132285
Afg3l2par/Afg3l2par
(Not Specified)
liver/biliary system phenotype J:132285
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H)
liver/biliary system phenotype J:226537
Afptm1(Cebpa)Ndw/Afp+
(involves: 129S7/SvEvBrd)
increased liver glycogen level J:103404
Agatm1Vk/Agatm1Vk
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
multifocal hepatic necrosis J:91114
Agap2tm1Kye/Agap2tm1Kye
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * DBA/2)
decreased liver cholesterol level J:174775
decreased liver free fatty acids level J:174775
decreased liver triglyceride level J:174775
Agltm1a(EUCOMM)Wtsi/Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
abnormal hepatocyte morphology J:212003
enlarged liver J:212003
increased liver glycogen level J:212003
liver fibrosis J:212003
Agltm1Geno/Agltm1Geno
(C57BL/6J-Agltm1Geno)
abnormal hepatocyte morphology J:218471
abnormal liver morphology J:218471
enlarged liver J:218471
increased liver glycogen level J:218471
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
abnormal liver morphology J:186035
enlarged liver J:186035
hepatic steatosis J:186035
liver inflammation J:186035
pale liver J:186035
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac)
hepatic steatosis J:146649
increased liver triglyceride level J:231617, J:146649
increased liver weight J:231617, J:146649
Agpat2tm1Garg/Agpat2tm1Garg
Mogat1tm1Far/Mogat1tm1Far

(involves: 129S4/SvJae * 129S6/SvEvTac)
increased liver triglyceride level J:231617
increased liver weight J:231617
Agpat5Gt(OST62319)Lex/Agpat5Gt(OST62319)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
hepatic steatosis J:103485
Agrptm1Dgen/Agrptm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
abnormal liver physiology J:199803
decreased liver triglyceride level J:199803
Agttm1Ii/Agttm1Ii
(involves: 129P2/OlaHsd * C57BL/6)
decreased liver weight J:30061
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased liver weight J:83597
hepatic steatosis J:33827
liver hyperplasia J:33827
pale liver J:33827
small liver J:33827
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra)
abnormal hepatocyte morphology J:64483
abnormal liver sinusoid morphology J:64483
decreased liver weight J:64483
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
abnormal hepatocyte morphology J:25048, J:44690
abnormal liver morphology J:25048, J:44690
abnormal liver physiology J:25048
bile duct inflammation J:25048
decreased liver weight J:25048
increased hepatoma incidence J:44690
increased liver adenoma incidence J:44690
liver fibrosis J:25048, J:44690
Ahrtm1Yfk/Ahrtm1Yfk
Nfe2l2tm1Mym/Nfe2l2tm1Mym

(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J * ICR)
hepatic steatosis J:82937
Ahrtm2Bra/Ahrtm2Bra
(involves: 129/Sv * C57BL/6)
decreased liver weight J:83597
Ahrtm4.1Bra/Ahrtm4.1Bra
(involves: 129/Sv * C57BL/6)
hepatic steatosis J:141978
small liver J:141978
Aif1ltm1b(EUCOMM)Wtsi/Aif1ltm1b(EUCOMM)Wtsi
(C57BL/6N-Aif1ltm1b(EUCOMM)Wtsi/Bay)
abnormal liver morphology J:211773
Aiptm1Bra/Aip+
(Not Specified)
decreased liver weight J:167350
Aiptm2Bra/Aiptm2Bra
(involves: 129)
decreased liver weight J:167350
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2(B6)-Airetm1.1Doi/Doi)
liver inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(C.129S2-Airetm1.1Doi/Doi)
liver inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(SJL.129S2-Airetm1.1Doi/Doi)
liver inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6 * NOD)
liver inflammation J:107432
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6)
liver inflammation J:77873
Airetm1Pltn/Airetm1Pltn
(B6.129S4-Airetm1Pltn)
liver inflammation J:115076
Akap10tm1.1(KOMP)Vlcg/Akap10+
(C57BL/6N-Akap10tm1.1(KOMP)Vlcg/Ucd)
abnormal liver size J:211773
Akap12tm1Ihg/Akap12tm1Ihg
(involves: 129S4/SvJae * C57BL/6)
liver inflammation J:138882
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129)
hepatic steatosis J:208505
increased liver triglyceride level J:208505
increased liver weight J:208505
Akt1tm1Mbb/Akt1tm1Mbb
(involves: 129P2/OlaHsd)
decreased hepatocyte number J:96823
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
decreased liver triglyceride level J:182721
decreased susceptibility to hepatic steatosis J:182721
Akt2tm1.1Mbb/Akt2+
Lepob/Lepob

(B6.Cg-Lepob Akt2tm1.1Mbb)
decreased liver triglyceride level J:155432
decreased liver weight J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd)
decreased liver triglyceride level J:160759
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(B6.129P2-Akt2tm1.1Mbb)
decreased liver triglyceride level J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Lepob/Lepob

(B6.Cg-Lepob Akt2tm1.1Mbb)
decreased liver triglyceride level J:155432
decreased liver weight J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
abnormal liver morphology J:218587
decreased susceptibility to hepatic steatosis J:218587
liver/biliary system phenotype J:160759
Akt2tm1.2Mbb/Akt2tm1.2Mbb
Lepob/Lepob
Tg(Alb1-cre)1Khk/0

(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)
decreased liver triglyceride level J:155432
decreased liver weight J:155432
Akt2tm1.2Mbb/Akt2tm1.2Mbb
Tg(Alb1-cre)1Khk/0

(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)
decreased liver triglyceride level J:155432
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
Trp53tm1Tyj/Trp53tm1Tyj

(involves: 129S2/SvPas * C57BL/6N)
liver inflammation J:276210
Albtm1(cre/ERT2)Mtz/Alb+
Fth1tm1.1Lck/Fth1tm1.1Lck

(involves: 129/Sv * C57BL/6 * SJL)
abnormal liver iron level J:166515
liver/biliary system phenotype J:166515
Albtm1(cre/ERT2)Mtz/Alb+
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+

(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6)
increased cholangiocarcinoma incidence J:192740
Albtm1(cre/ERT2)Mtz/Alb+
Hcfc1tm1Lwh/Hcfc1+

(involves: 129S2/SvPas * C57BL/6)
decreased liver regeneration J:231596
Albtm1(cre/ERT2)Mtz/Alb+
Krastm4Tyj/Kras+
Ptentm2Mak/Ptentm2Mak

(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae)
increased cholangiocarcinoma incidence J:254370
increased hepatocellular carcinoma incidence J:254370
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz
Slc2a2tm2Thor/Slc2a2tm2Thor

(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
decreased liver cholesterol level J:197607
decreased liver triglyceride level J:197607
increased liver glycogen level J:197607
Aldh1a1tm1Gdu/Aldh1a1tm1Gdu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal hepatobiliary system physiology J:83957
Aldh2tm1.1Mak/Aldh2+
(involves: 129S6/SvEvTac * C57BL/6J)
increased hepatocyte apoptosis J:223796
Aldh2tm1.1Mak/Aldh2tm1.1Mak
(involves: 129S6/SvEvTac * C57BL/6J)
increased hepatocyte apoptosis J:223796
Aldobtm1(KOMP)Vlcg/Aldobtm1(KOMP)Vlcg
(C57BL/6NTac-Aldobtm1(KOMP)Vlcg)
abnormal liver morphology J:220330
abnormal portal triad morphology J:220330
hepatic steatosis J:220330
liver fibrosis J:220330
liver inflammation J:220330
pale liver J:220330
Alms1foz/Alms1foz
(involves: NOD)
abnormal hepatocyte morphology J:107058
enlarged liver J:107058
hepatic steatosis J:107058
increased liver weight J:107058
liver fibrosis J:107058
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
hepatic steatosis J:100403
increased liver weight J:100403
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD)
hepatic steatosis J:118221
Amacrtm1Jkh/Amacrtm1Jkh
(involves: 129S1/Sv * 129X1/SvJ)
abnormal bile composition J:90370
enlarged liver J:90370
hepatic necrosis J:90370
AmfrGt(IST12797A11)Tigm/AmfrGt(IST12797A11)Tigm
(C57BL/6-AmfrGt(IST12797A11)Tigm)
abnormal hepatocyte morphology J:221247
abnormal liver morphology J:221247
hepatic steatosis J:221247
increased liver tumor incidence J:221247
liver cirrhosis J:221247
liver fibrosis J:221247
liver inflammation J:221247
Anapc2tm1Kna/Anapc2tm1Kna
Tg(Ttr-cre/Esr1*)1Vco/0

(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
abnormal hepatocyte morphology J:87782
increased hepatocyte proliferation J:87782
liver failure J:87782
Anapc2tm1Kna/Anapc2tm2Kna
Tg(Mx1-cre)1Cgn/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
abnormal hepatocyte morphology J:87782
abnormal liver physiology J:87782
increased hepatocyte proliferation J:87782
liver failure J:87782
Angptl3tm1Kfuj/Angptl3tm1Kfuj
(B6.129S1-Angptl3tm1Kfuj)
abnormal liver physiology J:107479
increased liver weight J:107479
Ank1ity16/Ank1+
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
increased liver iron level J:199427
Ank1ity16/Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
increased liver iron level J:199427
jaundice J:199427
liver abscess J:199427
Ank1M1Wlst/Ank1M1Wlst
(involves: 129S1/SvImJ * C3H/HeJ * C57BL/6)
gallstones J:170562
jaundice J:170562
Ank1MRI23420/Ank1MRI23420
(SJL/J-Ank1MRI23420)
jaundice J:187820
Ank1nb/Ank1nb
(either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re))
enlarged liver J:30699
gallstones J:6371
jaundice J:30699
Ank1nb/Ank1nb
(involves: C57BL/6J * WB/Re)
increased liver iron level J:3122
Ank1nb/Ank1nb
((WB.Cg-Ank1nb/BrkJ x B6.Cg-Ank1nb/BrkJ)F1)
enlarged liver J:162532
jaundice J:162532
Ank1RBC2/Ank1RBC2
(involves: 129S1/Sv * BALB/c)
increased liver iron level J:148127
jaundice J:148127
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J)
hepatic steatosis J:222913
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J)
hepatic steatosis J:222913
Anks6b2b1801.1Clo/Anks6b2b1801.1Clo
(C57BL/6J-Anks6b2b1801.1Clo)
abnormal liver morphology J:175213
anx/anx
(B6C3Fe a/a-anx/J)
abnormal liver morphology J:7689
anx/anx
(involves: DW/J * M. m. domesticus poschiavinus * Swiss)
abnormal liver morphology J:13936
Anxa7tm1Pll/Anxa7+
(B6.Cg-Anxa7tm1Pll)
increased hepatocellular carcinoma incidence J:93685
ApcMin/Apc+
(C57BL/6J-ApcMin)
hepatic steatosis J:86036
ApcMin/Apctm1Tno
Ctnnb1tm4.1Wbm/Ctnnb1+

(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
increased hepatocellular carcinoma incidence J:156864
Apctm1Rak/Apc+
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocellular carcinoma incidence J:20443
Apctm1Tno/Apc+
(involves: 129 * 129S4/SvJae * C57BL/6)
increased hepatocellular carcinoma incidence J:156864
Apctm1Tno/Apctm1Tno
(involves: 129 * 129S4/SvJae * C57BL/6)
increased hepatocellular carcinoma incidence J:156864
Apctm2.1Cip/Apctm2.1Cip
(involves: 129P2/OlaHsd * C57BL/6N)
increased hepatocellular carcinoma incidence J:94721
liver hyperplasia J:94721
Apctm2.1Cip/Apctm2.1Cip
Lect2tm1Ymg/Lect2tm1Ymg
Tg(Ttr-cre/Esr1*)1Vco/0

(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
abnormal liver morphology J:184496
hepatic necrosis J:184496
increased hepatocyte apoptosis J:184496
liver inflammation J:184496
Apctm2.1Cip/Apctm2.1Cip
Tg(Ttr-cre/Esr1*)1Vco/0

(B6.Cg-Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
abnormal liver morphology J:184496
enlarged liver J:184496
liver inflammation J:184496
Apctm2Rfo/Apc+
(B6.129P2-Apctm2Rfo)
increased liver tumor incidence J:151494
Apctm2Rfo/Apc+
((C57BL/6J x 129P2/OlaHsd)F1)
increased liver tumor incidence J:151494
Apctm2Rfo/Apc+
(129P2/OlaHsd-Apctm2Rfo)
increased liver tumor incidence J:151494
Apctm2Tno/Apc+
(involves: C57BL/6J)
hepatic steatosis J:86036
Apex1tm1Djc/Apex1+
(involves: 129X1/SvJ * NTac:NIHS)
abnormal liver morphology J:92957
Apoa1tm1(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J)
abnormal liver physiology J:81908
Apoa1tm1Unc/Apoa1tm1Unc
Ldlrtm1Her/Ldlrtm1Her

(B6.129-Ldlrtm1Her Apoa1tm1Unc)
abnormal liver morphology J:85174
decreased liver cholesterol level J:85174
Apoa1tm2(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J)
abnormal liver physiology J:81908
Apobtm1.1Zc/Apob+
(involves: 129X1/SvJ * C57BL/6)
hepatic steatosis J:65191
Apobtm1.1Zc/Apobtm1.1Zc
(involves: 129X1/SvJ * C57BL/6)
hepatic steatosis J:65191
Apobtm1Zc/Apob+
(involves: 129/Sv * C57BL/6)
hepatic steatosis J:76047
Apobtm1Zc/Apobtm1.1Zc
(involves: 129/Sv * C57BL/6)
hepatic steatosis J:76047
Apobtm1Zc/Apobtm1Zc
(involves: 129/Sv * C57BL/6)
hepatic steatosis J:76047
Apobtm4Sgy/Apobtm4Sgy
(involves: 129S4/SvJae * C57BL/6)
herniated liver J:46549
Apoc1tm1Lmh/Apoc1tm1Lmh
(involves: 129P2/OlaHsd * C57BL/6)
abnormal bile composition J:117482
increased liver triglyceride level J:117482
Apoc1tm1Lmh/Apoc1tm1Lmh
Tg(CETP)5203Tall/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA/J)
abnormal bile composition J:117482
increased liver triglyceride level J:117482
Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
(involves: 129P2/OlaHsd * C57BL/6)
liver/biliary system phenotype J:48565
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0

(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev)
decreased liver cholesterol level J:219838
decreased liver triglyceride level J:219838
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
abnormal liver physiology J:104609
Apoetm1Unc/Apoetm1Unc
Cyp19a1tm1Esi/Cyp19a1tm1Esi

(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
abnormal liver morphology J:184647
hepatic steatosis J:184647
increased liver weight J:184647
Apoftm1(KOMP)Vlcg/Apoftm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
increased liver cholesterol level J:185314
Aqp11tm1.1Nlsn/Aqp11tm1.1Nlsn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * C57BL/6 * DBA)
abnormal hepatocyte morphology J:194939
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0

(involves: 129S/SvEv * C57BL/6J * FVB/N)
increased liver triglyceride level J:98775
Arf6tm1Yaka/Arf6tm1Yaka
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hepatic cord morphology J:111404
abnormal liver development J:111404
abnormal liver morphology J:111404
decreased liver weight J:111404
liver hypoplasia J:111404
pale liver J:111404
Arg1tm1Rki/Arg1tm1Rki
(Not Specified)
abnormal hepatobiliary system morphology J:83263
abnormal hepatocyte morphology J:83263
abnormal liver morphology J:83263
enlarged liver J:83263
pale liver J:83263
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac)
liver hypoplasia J:101418
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6)
liver hypoplasia J:119516
Arid3atm1Pwt/Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6)
liver hypoplasia J:169178
Arid4atm1Alb/Arid4atm1Alb
(involves: 129S7/SvEvBrd)
enlarged liver J:141004
Arid4atm1Alb/Arid4atm1Alb
Arid4btm1Alb/Arid4b+

(involves: 129S7/SvEvBrd)
enlarged liver J:141004
Arih2tm1Mak/Arih2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
liver inflammation J:191066
Arih2tm1Mak/Arih2tm1Mak
(B6.129P2-Arih2tm1Mak)
abnormal liver physiology J:191066
liver hypoplasia J:191066
Arl3Gt(OST263303)Lex/Arl3Gt(OST263303)Lex
(involves: 129S5/SvEvBrd)
abnormal bile duct development J:107331
abnormal bile duct morphology J:107331
abnormal extrahepatic bile duct morphology J:107331
bile duct inflammation J:107331
dilated gallbladder J:107331
Arnt2em1Btlr/Arnt2em1Btlr
(C57BL/6J-Arnt2em1Btlr)
hepatic steatosis J:268298
increased liver weight J:268298
Arnttm1Bra/Arnttm1Bra
Hprttm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae

(involves: 129 * BALB/c * C57BL/6)
hepatic steatosis J:97652
Arnttm1Bra/Arnttm1Bra
Vhltm1Jae/Vhltm1Jae
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129 * BALB/c * C57BL/6 * DBA)
liver/biliary system phenotype J:97652
Arntltm1.1Shbi/Arntltm1.1Shbi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * C57BL/6J * DBA)
liver/biliary system phenotype J:177865
Arntltm1.2Shbi/Arntltm1.2Shbi
(involves: C57BL/6J)
hepatic steatosis J:177865
increased liver triglyceride level J:177865
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to hepatic steatosis J:179646
Arsgtm1Tdi/Arsgtm1Tdi
(involves: 129/Sv * C57BL/6)
abnormal hepatocyte morphology J:185592
abnormal liver sinusoid morphology J:185592
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
liver/biliary system phenotype J:241193
As3mttm1Djth/As3mttm1Djth
(involves: 129S6/SvEvTac * C57BL/6)
abnormal liver physiology J:162148
Asah1tm1Esc/Asah1+
(involves: 129S1/Sv * C57BL/6)
abnormal liver morphology J:74647
pale liver J:74647
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1)
hepatic necrosis J:232306
Asgr1tm1Ishi/Asgr1tm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6)
abnormal liver physiology J:68876
Aspscr1em1(IMPC)Tcp/Aspscr1em1(IMPC)Tcp
(C57BL/6NCrl-Aspscr1em1(IMPC)Tcp/Tcp)
abnormal liver morphology J:211773
Asxl1tm1.1Mjxu/Asxl1+
(involves: 129 * C57BL/6)
abnormal liver morphology J:208085
enlarged liver J:208085
Atad5Gt(RRF055)Byg/Atad5+
(involves: 129P2/OlaHsd)
increased liver adenocarcinoma incidence J:176672
Atf2tm2Nicj/Atf2tm2Nicj
Atf7tm1Nicj/Atf7tm1Nicj

(involves: 129P2/OlaHsd * C57BL/6)
abnormal liver morphology J:123909
increased hepatocyte apoptosis J:123909
liver hypoplasia J:123909
Atf4tm1Tow/Atf4tm1Tow
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss)
decreased hepatocyte number J:74479
pale liver J:74479
Atf6tm1.1Rjk/Atf6tm1.1Rjk
(involves: C57BL/6 * FVB/N)
hepatic steatosis J:124971
Atg5tm1Myok/Atg5tm1Myok
Tg(CAG-cre)13Miya/?

(involves: 129S/SvEv * C57BL/6)
abnormal liver morphology J:110050
Atg5tm1Myok/Atg5tm1Myok
Tg(Mx1-cre)1Cgn/?

(involves: 129S/SvEv * C57BL/6 * CBA)
abnormal liver morphology J:110050
Atg5tm1Nmz/Atg5tm1Nmz
(involves: 129S1/Sv * 129X1/SvJ)
abnormal hepatocyte morphology J:110050
abnormal liver morphology J:110050
Atg7tm1Tchi/Atg7tm1Tchi
Sqstm1tm1Keta/Sqstm1tm1Keta
Tg(Mx1-cre)1Cgn/0

(involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA * CBA/JNCrlj)
abnormal hepatocyte morphology J:130839
decreased liver function J:130839
Atg7tm1Tchi/Atg7tm1Tchi
Tg(Mx1-cre)1Cgn/0

(involves: C57BL/6 * CBA)
abnormal hepatocyte morphology J:130839, J:100199
abnormal liver morphology J:100199
abnormal liver physiology J:100199
decreased liver function J:130839
enlarged liver J:100199
increased hepatocyte proliferation J:130839
increased liver weight J:130839, J:100199
Atmtm1Awb/Atmtm1Awb
(A.129S6-Atmtm1Awb)
increased hepatocellular carcinoma incidence J:208539
Atox1Gt(IRESBetageo)3Pgr/Atox1Gt(IRESBetageo)3Pgr
(B6.129(Cg)-Atox1Gt(IRESBetageo)3Pgr/Mmucd)
decreased liver copper level J:74249
Atp6ap2tm1.1Aich/Y
Tg(Mx1-cre)1Cgn/0

(involves: C57BL/6 * C57BL/6J * CBA/J)
abnormal hepatocyte morphology J:274386
abnormal hepatocyte physiology J:274386
enlarged liver J:274386
Atp6ap2tm1.1Aich/Atp6ap2tm1.1Aich
Tg(Mx1-cre)1Cgn/0

(involves: C57BL/6 * C57BL/6J * CBA/J)
abnormal hepatocyte morphology J:274386
abnormal hepatocyte physiology J:274386
enlarged liver J:274386
Atp7aMo-blo/Y
(involves: C57BL/6J)
decreased liver copper level J:36268
Atp7aMo-blo/Atp7a+
(involves: C57BL/6J)
decreased liver copper level J:36268
Atp7aMo-br/Y
(involves: C57BL)
abnormal liver copper level J:5462
Atp7aMo-brJ/Y
(involves: C3H/HeJ * C57BL/6J)
decreased liver copper level J:33276
Atp7aMo-ml/Y
(involves: C3Hf/He)
decreased liver copper level J:12745, J:1132
Atp7aMo-ms/Y
(Not Specified)
decreased liver copper level J:168658
Atp7aMo-ms/Y
(involves: CBA/Kw)
decreased liver copper level J:14875
Atp7btm1Tcg/Atp7btm1Tcg
(involves: 129S1/Sv)
abnormal liver copper level J:57632
abnormal liver morphology J:57632
liver cirrhosis J:57632
liver/biliary system phenotype J:57632
Atp7btx-J/Atp7btx-J
(C3H/HeJ-Atp7btx-J/J)
abnormal liver morphology J:130273, J:86701
liver cirrhosis J:24233
Atp7btx/Atp7btx
(DL-Atp7btx)
abnormal hepatocyte morphology J:19226
decreased liver copper level J:7102
increased liver copper level J:19226, J:7102, J:40104
liver cirrhosis J:40104
Atp7btx/Atp7btx
(involves: C57BL/6 * DL)
decreased liver copper level J:7102
increased liver copper level J:7102
Atp8b1tm1Nbf/Atp8b1tm1Nbf
(involves: 129S1/SvImJ * 129S4/SvJae)
abnormal bile secretion J:89817
abnormal liver physiology J:89817
enlarged liver J:89817
Atp8b1tm1Nbf/Atp8b1tm1Nbf
Portm1Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
abnormal bile secretion J:215915
bile duct proliferation J:215915
cholestasis J:215915
increased liver weight J:215915
Atp11atm1a(KOMP)Wtsi/Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi)
enlarged liver sinusoidal spaces J:239583
herniated liver J:239583
liver hypoplasia J:239583
Atp11cambr/Y
(C57BL/6-Atp11cambr)
increased hepatocellular carcinoma incidence J:171924
Atrtm1Bal/Atrtm2Bal
Ndor1Tg(UBC-cre/ERT2)1Ejb/0

(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
abnormal liver morphology J:123200
Atrtm1Ofc/Atrtm1Ofc
(Not Specified)
decreased liver weight J:151542
Atxn2tm1.1Geno/Atxn2tm1.1Geno
(involves: 129P2/OlaHsd * C57BL/6)
hepatic steatosis J:135320
increased liver glycogen level J:135320
Atxn2tm1Plt/Atxn2tm1Plt
(involves: 129X1/SvJ * C57BL/6)
hepatic steatosis J:103805
intrahepatic cholestasis J:103805
AurkaGt(XQ0149)Wtsi/Aurka+
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatoma incidence J:143099
Aurkbtm1.2Mama/Aurkb+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL)
increased liver adenocarcinoma incidence J:173575
Auts2em1(IMPC)Wtsi/Auts2em1(IMPC)Wtsi
(C57BL/6N-Auts2em1(IMPC)Wtsi/Wtsi)
biliary cyst J:239583
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
liver degeneration J:54681
Azin1Gt(Ayu17-689)Imeg/Azin1Gt(Ayu17-689)Imeg
(involves: C57BL/6 * CBA)
abnormal liver parenchyma morphology J:146570
b2b386.2Clo/b2b386.2Clo
(C57BL/6J-b2b386.2Clo)
abnormal liver morphology J:175213
b2b386Clo/b2b386Clo
(C57BL/6J-b2b386Clo)
abnormal liver morphology J:175213
b2b1297Clo/b2b1297Clo
(C57BL/6J-b2b1297Clo)
abnormal liver morphology J:175213
liver cysts J:175213
b2b1801Clo/b2b1801Clo
(C57BL/6J-b2b1801Clo)
abnormal liver morphology J:175213
b2b2025Clo/b2b2025Clo
(C57BL/6J-b2b2025Clo)
abnormal liver morphology J:175213
b2b2821Clo/b2b2821Clo
(C57BL/6J-b2b2821Clo)
abnormal liver morphology J:175213
B2mtm1Unc/B2mtm1Unc
Hfetm2Nca/Hfetm2Nca

(involves: 129S6/SvEvTac * C57BL/6J)
increased liver iron level J:62112
B2mtm1Unc/B2mtm1Unc
Prkdcscid/Prkdcscid

(NOD.Cg-B2mtm1Unc Prkdcscid)
increased liver iron level J:102141
B9d1tm1a(EUCOMM)Wtsi/B9d1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * CD-1)
abnormal bile duct development J:178421
abnormal liver morphology J:178421
bile duct hyperplasia J:178421
B9d1tm1d(EUCOMM)Wtsi/B9d1tm1d(EUCOMM)Wtsi
(involves: C57BL/6 * FVB/N * SJL)
abnormal hepatobiliary system morphology J:178421
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/0

(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
abnormal hepatocyte morphology J:123547
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tnfrsf4tm2(cre)Nik/Tnfrsf4+

(involves: 129S6/SvEvTac * 129X1/SvJ)
liver inflammation J:169839
B9d2/Tgfb1tm1Flv/B9d2+
Tnfrsf4tm2(cre)Nik/Tnfrsf4+

(involves: 129S6/SvEvTac * 129X1/SvJ)
liver inflammation J:169839
B9d2tm1a(EUCOMM)Wtsi/B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi)
abnormal liver morphology J:239583
Bag1tm1Msd/Bag1tm1Msd
(involves: C57BL/6)
liver hypoplasia J:95491
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
decreased liver weight J:144416
hepatic steatosis J:144416
pale liver J:144416
Bambitm1.1(KOMP)Vlcg/Bambitm1.1(KOMP)Vlcg
(C57BL/6N-Bambitm1.1(KOMP)Vlcg/Ucd)
abnormal liver morphology J:211773
Bbs2tm1Vcs/Bbs2tm1Vcs
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
hepatic steatosis J:94467
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd)
abnormal liver morphology J:134093
abnormal liver physiology J:134093
enlarged liver J:134093
hepatic steatosis J:134093
Bcar1tm1Hhi/Bcar1tm1Hhi
(involves: 129S/SvEv * C57BL/6)
small liver J:48967
Bckdhatm1a(EUCOMM)Hmgu/Bckdhatm1a(EUCOMM)Hmgu
Tg(Ucp1-cre)1Evdr/0

(involves: C57BL/6N * FVB)
increased liver triglyceride level J:278806
increased liver weight J:278806
BckdkGt(VICT48)710Lex/BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex)
increased liver weight J:117564
Bcl2l12tm1.1(KOMP)Vlcg/Bcl2l12tm1.1(KOMP)Vlcg
(C57BL/6N-Bcl2l12tm1.1(KOMP)Vlcg/Ucd)
abnormal liver morphology J:211773
Bcl2l15tm1b(EUCOMM)Hmgu/Bcl2l15tm1b(EUCOMM)Hmgu
(C57BL/6N-Bcl2l15tm1b(EUCOMM)Hmgu/Ieg)
abnormal liver morphology J:211773
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6 * FVB/NJ)
decreased liver triglyceride level J:271078
decreased liver weight J:271078
decreased susceptibility to hepatic steatosis J:271078
Bcl6tm1Rdf/Bcl6tm1Rdf
(involves: 129S1/Sv)
liver inflammation J:40769
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv)
liver inflammation J:40769
Bco1tm1Dnp/Bco1tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6)
hepatic steatosis J:128383
Bco2tm1Dnp/Bco2+
(involves: 129S6/SvEvTac * C57BL/6)
hepatic steatosis J:170742
increased liver triglyceride level J:170742
Bco2tm1Dnp/Bco2tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6)
abnormal hepatocyte physiology J:170742
abnormal liver morphology J:166153
hepatic steatosis J:170742
increased liver triglyceride level J:170742
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas)
abnormal liver parenchyma morphology J:23804
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(involves: 129 * 129S6/SvEvTac * C57BL/6)
abnormal liver morphology J:189652
decreased liver glycogen level J:189652
hepatic steatosis J:189652
increased liver iron level J:189652
liver fibrosis J:189652
small liver J:189652
Becn1tm1Blev/Becn1+
(involves: 129X1/SvJ * C57BL/6J)
increased hepatocellular carcinoma incidence J:86953
Becn1tm1Htz/Becn1+
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocellular carcinoma incidence J:86982
Bhlha15tm2(Kras)Skz/Bhlha15+
(involves: 129S6/SvEvTac * C57BL/6)
enlarged liver J:105076
increased hepatocellular carcinoma incidence J:105076
increased liver adenoma incidence J:105076
Bhlha15tm2(Kras)Skz/Bhlha15+
Trp53tm1Tyj/Trp53+

(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
increased hepatocellular carcinoma incidence J:105076
Bhmttm1.2Zei/Bhmttm1.2Zei
(involves: 129P2/OlaHsd * C57BL/6)
abnormal liver morphology J:177569
hepatic steatosis J:177569
increased hepatocellular carcinoma incidence J:177569
increased liver adenoma incidence J:177569
increased liver tumor incidence J:177569
increased liver weight J:177569
Bicc1jcpk-67Gso/Bicc1jcpk-67Gso
T(2;10)67Gso/T(2;10)67Gso

(involves: 101/Rl * C3H/Rl * C57BL10a/E * SEC/RlGso)
abnormal biliary ductule morphology J:75799
abnormal interlobular bile duct morphology J:75799
abnormal liver morphology J:75799
abnormal liver parenchyma morphology J:75799
biliary cyst J:75799
jaundice J:75799
Bicc1jcpk-bpk/Bicc1jcpk-bpk
(BALB/c-Bicc1jcpk-bpk)
abnormal liver morphology J:13276
bile duct hyperplasia J:13276
Bicc1jcpk-bpk/Bicc1jcpk-bpk
(involves: BALB/c * CAST/EiJ)
dilated gallbladder J:36348
pale liver J:36348
Bicc1jcpk/Bicc1jcpk-bpk
(involves: 101 * BALB/c * C3H * C57BL/6J * T STOCK)
abnormal bile duct morphology J:36348
abnormal portal lobule morphology J:36348
abnormal portal triad morphology J:36348
dilated gallbladder J:36348
pale liver J:36348
Bicc1jcpk/Bicc1jcpk
(involves: 101 * C3H * C57BL/6J * T STOCK)
abnormal bile duct morphology J:36348
abnormal portal triad morphology J:36348
Bicc1jcpk/Bicc1jcpk
(involves: 101 * C3H * T STOCK)
dilated bile duct J:23047
enlarged gallbladder J:23047
Bicc1tm1Emdr/Bicc1tm1Emdr
(B6SJL-Bicc1tm1Emdr/J)
biliary cyst J:158678
Bidtm1Sjk/Bidtm1Sjk
(involves: 129X1/Sv * C57BL/6)
liver/biliary system phenotype J:132334
Bidtm1Sjk/Bidtm1Sjk
Relatm1Bal/Relatm1Bal

(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
abnormal liver morphology J:132334
liver hemorrhage J:132334
Bin3tm1Gcp/Bin3tm1Gcp
(involves: 129 * C57BL/6)
abnormal hepatocyte morphology J:133313
liver inflammation J:133313
Birc6tm1Nai/Birc6tm1Nai
(involves: 129S4/SvJae * C57BL/6J)
decreased hepatocyte number J:96768
Bloc1s2tm1.1(KOMP)Mbp/Bloc1s2tm1.1(KOMP)Mbp
(B6N(Cg)-Bloc1s2tm1.1(KOMP)Mbp/J)
pale liver J:211773
Bloc1s4cno/Bloc1s4cno
(C3H/HeJ-Bloc1s4cno)
abnormal liver physiology J:61187
Blvratm1c(EUCOMM)Hmgu/Blvratm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6J * C57BL/6N)
decreased liver glycogen level J:237631
hepatic steatosis J:237631
increased liver triglyceride level J:237631
BmcaAKR/J/BmcaAKR/J
(involves: A/J * AKR/J)
abnormal bile composition J:80014
Bmp4tm2Blh/Bmp4tm2Blh
(involves: 129S6/SvEvTac * Black Swiss)
abnormal liver bud morphology J:71204
delayed hepatic development J:71204
Bmp5se-Ca/Bmp5se-Ca
(CBA/Ca-Bmp5se-Ca)
abnormal liver morphology J:5086
Bmp5se-Ca/Bmp5se-Ca
(SEACGn.CB-Bmp5se-Ca)
abnormal liver morphology J:5086
Bmp5se/Bmp5se
(Ab/Gn)
decreased liver weight J:13091
Bmp5se/Bmp5se
(SEC/1Gn)
abnormal liver morphology J:5086
Bmp5se/Bmp5se
(SEAC/Gn)
abnormal liver morphology J:5086
bpck/bpck
(B6C3Fe a/a-bpck/J)
liver/biliary system phenotype J:144929
Bpnt1tm1Yrk/Bpnt1tm1Yrk
(involves: 129S/SvEv * C57BL/6)
abnormal hepatocyte morphology J:194247
enlarged liver J:194247
pale liver J:194247
Bpnt1tm1Yrk/Bpnt1tm1Yrk
Papss2bm/Papss2bm

(involves: 129S/SvEv * C57BL/6 * LDJ/Le)
liver/biliary system phenotype J:194247
Braftm1Cpri/Braf+
Tg(Mx1-cre)1Cgn/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
abnormal liver morphology J:104375
Braftm1Mmcm/Braftm1Mmcm
Cd207tm2.1(cre)Bjec/Cd207+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
liver inflammation J:211690
Braftm1Mmcm/Braftm1Mmcm
Tg(Itgax-cre)1-1Reiz/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
enlarged liver J:211690
Braftm1Tumg/Braf+
Tg(CAG-cre)2Osb/0

(involves: C57BL * C57BL/6J * DBA)
decreased liver weight J:216228
hepatic necrosis J:216228
small liver J:216228
Braftm1Tumg/Braf+
Tg(CAG-cre)2Osb/0

(involves: BALB/c * C57BL * C57BL/6J * DBA)
hepatic necrosis J:226977
Brca1tm2Cxd/Brca1tm2Cxd
Pkmtm1.1Mgvh/Pkmtm1.1Mgvh
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)4Mam/0

(involves: 129S4/SvJaeSor * 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)
increased liver tumor incidence J:205213
Brca1tm3Cxd/Brca1tm3Cxd
(involves: 129S6/SvEvTac * FVB/N)
increased hepatoma incidence J:94114
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
increased liver tumor incidence J:155810
Brd1tm1Hko/Brd1tm1Hko
(B6.129-Brd1tm1Hko)
decreased hepatoblast number J:177092
small liver J:177092
Brd2em1(IMPC)Wtsi/Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg)
abnormal gallbladder morphology J:239583
enlarged liver sinusoidal spaces J:239583
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg)
hepatic steatosis J:159964
Brd4Gt(pGT1.8TM)ST132Nimr/Brd4+
(involves: 129P2/Ola * C57BL/6J)
abnormal hepatocyte morphology J:76662
Brip1Gt(RRI409)Byg/Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd)
hepatic steatosis J:227115
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
enlarged liver J:183701
hepatic steatosis J:183701
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N)
enlarged liver J:173404
hepatic steatosis J:173404
increased liver triglyceride level J:173404
liver/biliary system phenotype J:173404
Bscl2tm1c(EUCOMM)Hmgu/Bscl2tm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6N * FVB/NJ)
increased liver triglyceride level J:260853
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno)
enlarged liver J:200947
hepatic steatosis J:200947
increased liver triglyceride level J:200947
increased liver weight J:200947
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas * C57BL/6J)
abnormal liver morphology J:46376
small liver J:46376
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129/Sv * 129S2/SvPas)
abnormal liver morphology J:46376
small liver J:46376
Bub1tm1.1Tvd/Bub1tm1.1Tvd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
increased liver tumor incidence J:143035
Bub1tm1.1Tvd/Bub1tm1.1Tvd
(B6.129P2-Bub1tm1.1Tvd)
hepatic necrosis J:143035
pale liver J:143035
Bub1tm2Jvd/Bub1tm2Jvd
(involves: 129/Sv * C57BL/6)
increased hepatocellular carcinoma incidence J:135093
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6)
increased hepatocellular carcinoma incidence J:201641
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex)
decreased liver cholesterol level J:241403
decreased liver triglyceride level J:241403
hepatic steatosis J:241403
increased liver triglyceride level J:241403
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
decreased liver triglyceride level J:237401
decreased susceptibility to hepatic steatosis J:237401
C1qtnf7tm1(KOMP)Vlcg/C1qtnf7tm1(KOMP)Vlcg
(C57BL/6N-C1qtnf7tm1(KOMP)Vlcg)
decreased liver weight J:244352
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
abnormal liver physiology J:212299
hepatic steatosis J:212299
increased liver triglyceride level J:212299
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
abnormal liver morphology J:152533
abnormal liver physiology J:152533
decreased hepatocyte proliferation J:152533
decreased liver regeneration J:152533
focal hepatic necrosis J:152533
hepatic steatosis J:152533
liver inflammation J:30152
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae)
decreased susceptibility to hepatic steatosis J:128218
C3tm1Hrc/C3tm1Hrc
(B6.129-C3tm1Hrc)
decreased liver regeneration J:91917
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
decreased liver regeneration J:91917
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6)
liver inflammation J:30152
C5ar2tm1Gdy/C5ar2tm1Gdy
(involves: 129 * C57BL/6)
abnormal liver morphology J:152533
focal hepatic necrosis J:152533
hepatic steatosis J:152533
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
enlarged liver J:240357
liver inflammation J:240357
C9orf72tm1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N)
enlarged liver J:240357
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N)
enlarged liver J:240357
cab/cab
(STOCK Cacna1smdg)
abnormal liver morphology J:6195, J:7797
Cacna1itm1b(KOMP)Wtsi/Cacna1itm1b(KOMP)Wtsi
(C57BL/6N-Cacna1itm1b(KOMP)Wtsi/Bay)
small liver J:211773
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
abnormal liver parenchyma morphology J:239583
Capza2tm1b(KOMP)Wtsi/Capza2tm1b(KOMP)Wtsi
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi)
biliary cyst J:239583
enlarged liver sinusoidal spaces J:239583
Casp8kuche/Casp8kuche
(involves: C57BL/6JAnu * C57BL/10SnJ)
small liver J:104190
Casp8tm1.1Raz/Casp8tm1.1Raz
Ripk3tm1Vmd/Ripk3tm1Vmd

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
abnormal liver physiology J:170815
decreased hepatocyte apoptosis J:170814
Casp8tm1Clie/Casp8tm1Clie
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0

(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
abnormal biliary tract morphology J:218665
abnormal liver morphology J:218665
enlarged liver J:218665
hepatic necrosis J:218665
intrahepatic cholestasis J:218665
liver fibrosis J:218665
Casp8tm1Clie/Casp8tm1Clie
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Alb1-cre)7Gsc/0

(involves: 129P2/OlaHsd * FVB/N)
abnormal bile duct morphology J:160521
abnormal liver morphology J:160521
bile duct proliferation J:160521
focal hepatic necrosis J:160521
Casp8tm1Clie/Casp8tm1Clie
Tg(Alb1-cre)7Gsc/0

(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
liver inflammation J:218665
Casp8tm1Raz/Casp8tm1Raz
Tg(Lck-cre)548Jxm/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
abnormal liver morphology J:107455
Casz1Gt(CJ0565)Wtsi/Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
liver vascular congestion J:242127
Catb/Catb
(C3.Cg-Catb/Anl)
increased hepatoma incidence J:154291
Cav1tm1Kur/Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6)
abnormal liver physiology J:112452
decreased hepatocyte proliferation J:112452
decreased liver regeneration J:112452
decreased liver triglyceride level J:112452
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
liver/biliary system phenotype J:75192
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls)
abnormal liver physiology J:182288
decreased liver glycogen level J:182288
decreased susceptibility to hepatic steatosis J:182288
increased liver glycogen level J:182288
increased liver weight J:182288
Cav1tm1Pesch/Cav1tm1Pesch
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(FVB.Cg-Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn)
liver/biliary system phenotype J:182288
Cavin3tm1Pemi/Cavin3tm1Pemi
(B6.129S4-Cavin3tm1Pemi)
hepatic steatosis J:202374
Cbfbtm1Lhc/Cbfbtm1Lhc
Tg(Mx1-cre)1Cgn/0

(involves: 129S6/SvEvTac * C57BL/6 * CBA)
abnormal liver morphology J:105040
Cbfbtm1Ppl/Cbfb+
(either: (involves: 129/Sv * 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))
pale liver J:36594
small liver J:36594
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)1Spe/0

(either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1))
abnormal liver morphology J:80670
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)2Spe/0

(either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster))
abnormal liver morphology J:80670
Cbfbtm1Tno/Cbfbtm1Tno
(involves: 129S4/SvJae * C57BL/6J)
abnormal liver development J:40963
Cbfbtm1Tok/Cbfbtm1Tok
(involves: 129P2/OlaHsd * C57BL/6J)
pale liver J:36250
Cbfbtm3Ppl/Cbfb+
(involves: 129S6/SvEvTac * C57BL/6)
pale liver J:160522
Cbfbtm4Ppl/Cbfb+
(involves: 129S6/SvEvTac * C57BL/6)
pale liver J:160522
Cbltm1.1Hua/Cbltm1.1Hua
Lattm1Les/Lattm1Les

(involves: 129P2/OlaHsd)
liver inflammation J:91369
Cbltm1.1Hua/Cbltm1.1Hua
Lcp2tm1Gak/Lcp2tm1Gak

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
liver inflammation J:91369
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6)
decreased liver triglyceride level J:94416
Cbltm2Hua/Cbltm2Hua
Cblbtm1Hua/Cblbtm1Hua
Tg(Lck-cre)I57Jxm/0

(involves: 129P2/OlaHsd * C57BL/6 * ICR)
liver fibrosis J:80427
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi)
abnormal hepatocyte morphology J:236022
Cbstm1Unc/Cbs+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal hepatocyte morphology J:23321
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal hepatocyte morphology J:23321
enlarged liver J:23321
hepatic steatosis J:23321, J:101303
increased hepatocyte apoptosis J:101303
liver fibrosis J:101303
liver inflammation J:101303
pale liver J:23321
Cbstm1Unc/Cbstm1Unc
Tg(CBS)11181Eri/0

(involves: 129P2/OlaHsd * C57BL/6J)
abnormal liver morphology J:165612
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi)
abnormal bile duct morphology J:239583
abnormal liver vasculature morphology J:239583
Cbx7tm1Afus/Cbx7+
(involves: C57BL/6J)
increased hepatocellular carcinoma incidence J:184383
increased liver adenoma incidence J:184383
Cbx7tm1Afus/Cbx7tm1Afus
(involves: C57BL/6J)
increased hepatocellular carcinoma incidence J:184383
increased liver adenoma incidence J:184383
increased liver tumor incidence J:184383
Ccar2Gt(XN876)Byg/Ccar2Gt(XN876)Byg
(involves: 129P2/OlaHsd * C57BL/6)
abnormal liver physiology J:156677
decreased susceptibility to hepatic steatosis J:156677
Ccbe1tm1Mlkn/Ccbe1tm1Mlkn
(either: B6.129-Ccbe1tm1Mlkn or (involves: 129 * C57BL/6))
abnormal liver morphology J:196696
small liver J:196696
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J)
decreased liver triglyceride level J:220560
decreased liver weight J:220560
decreased susceptibility to hepatic steatosis J:220560
Ccdc39b2b2025.1Clo/Ccdc39b2b2025.1Clo
(C57BL/6J-Ccdc39b2b2025.1Clo)
abnormal liver morphology J:175213
Ccdc80tm1.1Ftk/Ccdc80tm1.1Ftk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6N)
increased hepatocellular carcinoma incidence J:216704
Ccdc124tm1b(KOMP)Wtsi/Ccdc124tm1b(KOMP)Wtsi
(C57BL/6N-Ccdc124tm1b(KOMP)Wtsi/Nju)
small liver J:211773
Ccdc134tm1.2Jhua/Ccdc134tm1.2Jhua
(involves: C57BL/6NTac)
decreased hepatocyte proliferation J:256995
liver hypoplasia J:256995
small liver J:256995
Ccdc151tm1b(EUCOMM)Hmgu/Ccdc151tm1b(EUCOMM)Hmgu
(C57BL/6N-Ccdc151tm1b(EUCOMM)Hmgu)
abnormal liver morphology J:278798
Ccdc154ntl/Ccdc154ntl
(involves: 129S7/SvEvBrd * C57BL/6J)
enlarged liver J:226596
Cckartm1Kpn/Cckartm1Kpn
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)
gallstones J:53711
Cckartm1Kpn/Cckartm1Kpn
(involves: 129S/SvEv)
abnormal bile composition J:91998
dilated gallbladder J:91998
gallstones J:91998
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6J)
increased liver iron level J:142455
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J)
decreased susceptibility to hepatic steatosis J:110277
Ccn1tm3.1Lfl/Ccn1tm3.1Lfl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129 * C57BL/6 * DBA)
liver fibrosis J:204032
liver/biliary system phenotype J:204032
Ccn2tm1.1Alea/Ccn2tm1.1Alea
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA)
abnormal cholangiocyte morphology J:228499
increased liver weight J:228499
liver fibrosis J:228499
Ccn3tm1Cabo/Ccn3+
(involves: 129S/SvEv)
liver vascular congestion J:135676
Ccn3tm1Cabo/Ccn3tm1Cabo
(involves: 129S/SvEv)
liver vascular congestion J:135676
Ccnd2tm1Wbg/Ccnd2tm1Wbg
Ccnd3tm1Pisc/Ccnd3tm1Pisc

(Not Specified)
abnormal liver development J:80994
Ccndbp1tm1Riet/Ccndbp1tm1Riet
(involves: 129P2/OlaHsd * C57BL/6)
decreased hepatocyte proliferation J:121623
decreased liver regeneration J:121623
increased hepatocellular carcinoma incidence J:121623
increased liver adenoma incidence J:121623
Ccng1tm1Sst/Ccng1tm1Sst
(involves: 129S/SvEv * C57BL/6)
abnormal liver regeneration J:106007
decreased hepatoma incidence J:106007
decreased liver weight J:106007
increased hepatoma incidence J:106007
Ccnytm1.1Smoc/Ccnytm1.1Smoc
(involves: C57BL/6)
decreased liver triglyceride level J:224589
Ccr1tm1Gao/Ccr1tm1Gao
(involves: 129S4/SvJae)
abnormal Kupffer cell morphology J:152548
Ccr2tm1Brv/Ccr2tm1Brv
(involves: 129S1/Sv * ICR)
enlarged liver J:111517
liver inflammation J:111517
multifocal hepatic necrosis J:111517
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
hepatic necrosis J:61542
increased hepatocyte apoptosis J:61542
liver hemorrhage J:61542
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hepatocyte physiology J:100869
abnormal Ito cell morphology J:152548
abnormal Kupffer cell morphology J:152548
liver failure J:100869
Cd1d1tm1Luc/Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6)
abnormal liver morphology J:93915
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe)
abnormal liver physiology J:135594
decreased liver free fatty acids level J:135594
decreased liver triglyceride level J:135594
increased liver triglyceride level J:87372
Cd44tm1Mak/Cd44tm1Mak
(B6.129P2-Cd44tm1Mak)
liver inflammation J:69351
Cd72c/Cd72c
Faslpr/Faslpr

(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
liver inflammation J:204782
Cd72tm1Tsub/Cd72tm1Tsub
Faslpr/Faslpr

(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp)
liver inflammation J:204782
Cdc20tm1.1Pzg/Cdc20+
(involves: 129S7/SvEvBrd * C57BL/6)
increased hepatoma incidence J:150421
Cdc73tm1Btt/Cdc73tm1Btt
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129S4/SvJae * C57BL/6 * CBA)
hepatic necrosis J:135255
small liver J:135255
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst
(B6.Cg-Cdh5tm3(Cdh5/Ctnna1)Dvst)
decreased liver weight J:213676
liver hypoplasia J:213676
small liver J:213676
Cdh5tm8Dvst/Cdh5tm8Dvst
Commd10Tg(Vav1-icre)A2Kio/Commd10+

(involves: C57BL/10 * CBA/Ca)
liver/biliary system phenotype J:213676
Cdk1tm2.1Kald/Cdk1tm2.1Kald
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129 * C57BL/6 * DBA * SJL)
abnormal hepatocyte morphology J:182141
decreased hepatocyte number J:182141
decreased hepatocyte proliferation J:182141
Cdk2tm1Kald/Cdk2tm1Kald
(involves: 129S1/Sv)
decreased hepatocyte proliferation J:141249
Cdk2tm1Kald/Cdk2tm1Kald
Cdk4tm1Kiyo/Cdk4tm1Kiyo

(involves: 129S1/Sv * C57BL/6)
abnormal liver morphology J:108720
Cdk2tm1Sgo/Cdk2tm1Sgo
Cdk4tm1Bbd/Cdk4tm1Bbd
Cdk6tm1Bbd/Cdk6tm1Bbd

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
liver hypoplasia J:124678
Cdk2tm1Sgo/Cdk2tm1Sgo
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd

(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL)
abnormal liver physiology J:125217
liver hypoplasia J:125217
Cdk2tm2Sgo/Cdk2tm2Sgo
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
Polr2atm1(cre/ERT2)Bbd/?

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
liver/biliary system phenotype J:125217
Cdk4tm1Bbd/Cdk4tm1Bbd
Cdk6tm1Bbd/Cdk6tm1Bbd

(involves: 129S1/Sv * 129X1/SvJ * CD-1 * ICR)
liver hypoplasia J:92529
Cdk5rap3tm1b(EUCOMM)Hmgu/Cdk5rap3tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * FVB/N)
abnormal cholangiocyte morphology J:272566
abnormal hepatoblast differentiation J:272566
abnormal liver physiology J:272566
decreased hepatocyte proliferation J:272566
decreased liver weight J:272566
liver hypoplasia J:272566
small liver J:272566
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S4/SvJaeSor * C57BL/6N * DBA)
liver/biliary system phenotype J:272566
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu
Tg(Foxa3-cre)1Khk/0

(involves: 129S4/SvJaeSor * C57BL/6N * DBA)
abnormal hepatic cord morphology J:272566
abnormal hepatocyte morphology J:272566
abnormal hepatocyte physiology J:272566
decreased liver weight J:272566
liver hypoplasia J:272566
small liver J:272566
Cdk10tm1.2Kald/Cdk10tm1.2Kald
(involves: 129 * C57BL/6 * FVB/N)
abnormal liver morphology J:262333
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj)
decreased liver triglyceride level J:195460
increased liver triglyceride level J:195460
Cdkn1atm1(HBsAg)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1(HBsAg)Xya/Cdkn1atm1(HBsAg)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Ako/Cdkn1btm1Ako

(involves: 129S1/Sv * 129S2/SvPas)
hepatic steatosis J:118516
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Fahtm1Mgo/Fahtm1Mgo

(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
abnormal hepatocyte morphology J:138701
abnormal liver physiology J:138701
increased hepatocellular carcinoma incidence J:138701
increased hepatocyte apoptosis J:138701
increased hepatocyte proliferation J:138701
Cdkn1atm2(HBx)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm2(HBx)Xya/Cdkn1atm2(HBx)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss))
hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J)
abnormal hepatocyte morphology J:33400
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn
Nf2tm2Gth/Nf2tm2Gth

(involves: 129P2/OlaHsd * FVB/N)
increased liver tumor incidence J:131179
Cdkn2atm1.1Gsu/Cdkn2atm1.1Gsu
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0

(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N)
jaundice J:198619
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Rnf2tm1Mvi/Rnf2tm1Mvi
Tg(Mx1-cre)1Cgn/0

(involves: 129 * C57BL/6 * C57BL/10 * CBA * SJL)
enlarged liver J:130397
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0

(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N)
jaundice J:198619
Cdkn2atm2Brn/Cdkn2a+
Nf2tm2Gth/Nf2tm2Gth

(involves: 129P2/OlaHsd)
enlarged liver J:132943
Cdkn2atm2Brn/Cdkn2atm2Brn
Nf2tm2Gth/Nf2tm2Gth

(involves: 129P2/OlaHsd)
enlarged liver J:132943
Cebpatm1Dgt/Cebpatm1Dgt
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0

(involves: 129 * 129S6/SvEvTac * C57BL/6)
liver/biliary system phenotype J:105593
Cebpatm1Gjd/Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6)
abnormal hepatocyte morphology J:28320
abnormal liver morphology J:28320
Cebpatm1Gonz/Cebpatm1Gonz
Lepob/Lepob
Tg(Alb1-cre)1Dlr/0

(involves: 129X1/SvJ * C57BL/6J * FVB/N)
decreased liver cholesterol level J:93579
decreased liver triglyceride level J:93579
decreased susceptibility to hepatic steatosis J:93579
increased liver glycogen level J:93579
Cebpatm1Kgx/Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal bile canaliculus morphology J:35795
abnormal hepatocyte morphology J:35795
abnormal liver morphology J:35795
Cebpatm1Timc/Cebpatm1Timc
(Not Specified)
decreased hepatocyte proliferation J:163725
hepatic steatosis J:163725
Cebpatm5Nerl/Cebpatm5Nerl
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hepatocyte morphology J:120098
abnormal liver physiology J:120098
increased liver triglyceride level J:120098
liver/biliary system phenotype J:120098
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6)
abnormal liver physiology J:120098
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
decreased hepatocyte number J:136134
liver failure J:136134
liver inflammation J:136134
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6 * MF1)
decreased liver regeneration J:49673
Cebpbtm2.1Acle/Cebpbtm2.1Acle
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
decreased liver regeneration J:155795
Celtm1Dyh/Celtm1Dyh
Pnliptm1Dyh/Pnliptm1Dyh

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased liver weight J:124658
Celf4tm1a(EUCOMM)Wtsi/Celf4tm1a(EUCOMM)Wtsi
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi)
abnormal bile duct morphology J:239583
Cenpetm2Dwc/Cenpetm2Dwc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal liver regeneration J:81046
Cep290Gt(CC0582)Wtsi/Cep290Gt(CC0582)Wtsi
(129P2/OlaHsd-Cep290Gt(CC0582)Wtsi)
liver/biliary system phenotype J:212182
Cers2Gt(S16-4B1)Sor/Cers2Gt(S16-4B1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
increased hepatocellular carcinoma incidence J:156841
increased liver tumor incidence J:156841
Ces1dtm1Rile/Ces1dtm1Rile
(involves: 129S6/SvEvTac)
abnormal hepatocyte physiology J:158743
decreased liver triglyceride level J:158743
decreased liver weight J:158743
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6)
abnormal hepatocyte physiology J:262803
hepatic steatosis J:262803
increased liver cholesterol level J:262803
increased liver triglyceride level J:262803
liver degeneration J:262803
Cfap53em1(IMPC)Wtsi/Cfap53em1(IMPC)Wtsi
(C57BL/6N-Cfap53em1(IMPC)Wtsi/Wtsi)
abnormal liver morphology J:239583
enlarged liver sinusoidal spaces J:239583
herniated liver J:239583
Cfc1tm1Mms/Cfc1tm1Mms
(either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6J))
abnormal liver morphology J:58104
Cftrtm1Bay/Cftrtm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
enlarged gallbladder J:15244
Cftrtm1Eur/Cftrtm1Eur
(involves: 129P2/OlaHsd * FVB/N)
abnormal gallbladder physiology J:28979
Cftrtm1Unc/Cftrtm1Unc
(involves: 129P2/OlaHsd)
abnormal gallbladder morphology J:2079
dilated gallbladder J:2079
Cftrtm3Bay/Cftrtm3Bay
(involves: 129S7/SvEvBrd)
liver/biliary system phenotype J:29656
Cftrtm3Hgu/Cftrtm3Hgu
(involves: 129P2/OlaHsd)
abnormal bile duct morphology J:32766
abnormal hepatocyte morphology J:32766
bile duct epithelium hyperplasia J:32766
enlarged gallbladder J:32766
gallbladder inflammation J:32766
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
abnormal liver morphology J:146743
bile duct hyperplasia J:146743
hepatic necrosis J:146743
liver inflammation J:146743
ChkaGt(XH252)Byg/Chka+
(involves: 129P2/OlaHsd * C57BL/6)
increased liver triglyceride level J:130726
Chordc1tm1Mbra/Chordc1+
(involves: 129 * C57BL/6)
enlarged liver J:222040
Chrm2tm1Jwe/Chrm2tm1Jwe
(involves: 129S4/SvJae * CF-1)
abnormal gallbladder physiology J:125455
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
abnormal gallbladder physiology J:125455
Chrm4tm1Jwe/Chrm4tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
abnormal gallbladder physiology J:125455
Chst14tm1.1Msch/Chst14tm1.1Msch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased liver weight J:203583
Chuktm1Mpa/Chuktm1Mpa
Ikbkbtm2Cgn/Ikbkbtm2Cgn
Tg(Alb1-cre)7Gsc/0

(involves: C57BL/6 * FVB/N)
abnormal bile canaliculus morphology J:137861
abnormal bile duct morphology J:137861
intrahepatic cholestasis J:137861
jaundice J:137861
Chuktm1Ver/Chuktm1Ver
(involves: 129S4/SvJae * C57BL/6J)
dilated gallbladder J:55415
Chuktm1Ver/Chuktm1Ver
Ikbkbtm1Ver/Ikbkbtm1Ver

(involves: 129S4/SvJae * C57BL/6J)
increased hepatocyte apoptosis J:63443
liver degeneration J:63443
Ciapin1tm1Yzka/Ciapin1tm1Yzka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
small liver J:90889
Cidebtm1Pli/Cidebtm1Pli
(Not Specified)
liver/biliary system phenotype J:126556
Cidectm1.1Gonz/Cidectm1.2Gonz
Tg(Fabp4-cre)#Abel/?

(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel)
hepatic steatosis J:226899
Cidectm1Maka/Cidectm1Maka
(B6.129P2-Cidectm1Maka)
decreased susceptibility to hepatic steatosis J:140863
Clca2tm1Dgen/Clca2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hepatocyte morphology J:101679
enlarged liver J:101679
increased liver weight J:101679
multifocal hepatic necrosis J:101679
Clcn3tm1Suc/Clcn3tm1Suc
(involves: 129P2/OlaHsd * C57BL/6)
abnormal liver physiology J:96150, J:96311
Clcn5tm1Tjj/Y
(B6.129-Clcn5tm1Tjj)
liver/biliary system phenotype J:77111
Clec4gtm1.1Fhe/Clec4gtm1.1Fhe
(B6.129-Clec4gtm1.1Fhe)
liver inflammation J:200968
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6)
decreased susceptibility to hepatic steatosis J:160186
Clk2tm1.1Ppgr/Clk2tm1.1Ppgr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6NTac * FVB/N)
decreased liver triglyceride level J:229283
Cln3tm1.1Mem/Cln3tm1.1Mem
(involves: 129S/SvEv * CD-1)
abnormal hepatocyte morphology J:79615
Cln3tm1Mkat/Cln3tm1Mkat
(involves: 129X1/SvJ * C57BL/6J)
abnormal liver morphology J:57155
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt)
abnormal hepatocyte physiology J:98343
hepatic steatosis J:98343
Cluhtm1.1Eir/Cluhtm1.1Eir
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: BALB/cJ * C57BL/6 * DBA * SJL)
abnormal liver physiology J:249661
liver/biliary system phenotype J:249661
Cluhtm1.2Eir/Cluhtm1.2Eir
(involves: BALB/cJ * C57BL/6 * SJL)
abnormal liver physiology J:249661
Cmiptm1a(EUCOMM)Wtsi/Cmiptm1a(EUCOMM)Wtsi
(C57BL/6N-Cmiptm1a(EUCOMM)Wtsi/Wtsi)
abnormal liver vasculature morphology J:239583
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya)
decreased susceptibility to hepatic steatosis J:180033
small liver J:180033
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya)
decreased liver weight J:274297
decreased susceptibility to hepatic steatosis J:274297
Cnpy2tm1.2Zhli/Cnpy2tm1.2Zhli
(B6.Cg-Cnpy2tm1.2Zhli)
decreased susceptibility to hepatic steatosis J:277868
liver/biliary system phenotype J:277868
Cog6tm1a(EUCOMM)Wtsi/Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi)
abnormal liver vasculature morphology J:239583
Col1a1tm1(tetO-Deptor)Dmsa/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/?

(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
hepatic steatosis J:187378
increased liver weight J:187378
Col1a1tm1(tetO-Fos)Wag/Col1a1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Alb1-cre)7Gsc/0

(involves: 129 * C57BL/6 * FVB/N)
abnormal liver morphology J:210545
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
decreased susceptibility to hepatic steatosis J:177113
increased hepatocyte proliferation J:166568
liver hyperplasia J:166568
Col1a1tm1(tetO-Tcfap2c)Hsc/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+

(involves: 129S4/SvJae * C57BL/6)
abnormal hepatocyte morphology J:174049
decreased liver glycogen level J:174049
hepatic steatosis J:174049
increased hepatocyte apoptosis J:174049
increased hepatocyte proliferation J:174049
liver failure J:174049
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+
Tg(Cebpb-tTA)#Bjd/0

(involves: 129S4/SvJae * C57BL/6)
abnormal hepatocyte morphology J:141457
decreased hepatocyte apoptosis J:141457
enlarged liver J:141457
increased hepatocyte proliferation J:141457
increased liver weight J:141457
liver hyperplasia J:141457
Col1a1tm1Dab/Col1a1tm1Dab
(C.129S6-Col1a1tm1Dab)
abnormal liver morphology J:170561
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0

(involves: 129S4/SvJae * C57BL/6 * NMRI)
decreased liver triglyceride level J:210545
decreased susceptibility to hepatic steatosis J:210545
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+

(involves: 129S4/SvJae * C57BL/6)
liver fibrosis J:213764
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0

(involves: 129S4/SvJae * C57BL/6 * NMRI)
abnormal liver morphology J:210545
decreased liver triglyceride level J:210545
decreased liver weight J:210545
decreased susceptibility to hepatic steatosis J:210545
increased liver weight J:213764
liver inflammation J:210545
liver/biliary system phenotype J:213764
Col1a1tm4(tetO-Jun/Fosl2)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0

(involves: 129S4/SvJae * C57BL/6 * NMRI)
decreased liver triglyceride level J:210545
decreased susceptibility to hepatic steatosis J:210545
Col1a1tm5(tetO-Jun/Fos)Wag/Col1a1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Alb1-cre)7Gsc/0

(involves: 129 * C57BL/6 * FVB/N)
abnormal liver morphology J:210545
Col1a1tm6(tetO-MSI2)Jae/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+

(involves: 129S4/SvJae * C57BL/6)
increased liver weight J:163322
Col2a1tm1Prc/Col2a1tm1Prc
(involves: 129/Sv * C57BL/6)
liver/biliary system phenotype J:30041
Col3a1tm1Jae/Col3a1tm1Jae
(involves: 129S4/SvJae)
abnormal liver morphology J:39273
Commd1tm2.1Bvds/Commd1tm2.1Bvds
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S/SvEv * C57BL/6 * DBA * SJL)
increased liver copper level J:182331
Coq7tm1Hek/Coq7tm2Hek
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * C57BL/6NTac)
abnormal liver physiology J:202240
liver/biliary system phenotype J:202240
Coro1ctm1a(KOMP)Wtsi/Coro1ctm1a(KOMP)Wtsi
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi)
abnormal cystic duct morphology J:239583
dilated bile duct J:239583
enlarged liver sinusoidal spaces J:239583
Cox5btm2b(EUCOMM)Hmgu/Cox5btm2b(EUCOMM)Hmgu
(C57BL/6N-Cox5btm2b(EUCOMM)Hmgu/Bay)
abnormal liver size J:211773
pale liver J:211773
Cox6a1tm1(KOMP)Wtsi/Cox6a1tm1(KOMP)Wtsi
(involves: C57BL/6JJcl * C57BL/6N)
abnormal liver physiology J:230212
Cpm1Btlr/Cpm1Btlr
(C57BL/6J-Cpm1Btlr)
increased liver iron level J:173078
Cptm1Hrs/Cptm1Hrs
(involves: 129X1/SvJ * Black Swiss)
abnormal liver copper level J:71807
increased liver iron level J:57730, J:71807
Cptm1Samd/Cptm1Samd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased liver iron level J:78092
Cptm1Yos/Cptm1Yos
(involves: 129P2/OlaHsd * BALB/c)
abnormal hepatocyte morphology J:79916
abnormal Kupffer cell morphology J:79916
increased liver iron level J:79916
Cpetm1b(EUCOMM)Hmgu/Cpetm1b(EUCOMM)Hmgu
(C57BL/6N-Cpetm1b(EUCOMM)Hmgu/Ieg)
enlarged liver J:211773
Cpt1ctm1Mdln/Cpt1ctm1Mdln
(involves: C57BL/6)
hepatic steatosis J:109455
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp)
abnormal liver morphology J:208570
decreased liver triglyceride level J:208570
decreased liver weight J:208570
decreased susceptibility to hepatic steatosis J:208570
small liver J:208570
Crebbptm1Few/Crebbp+
(Not Specified)
increased liver glycogen level J:91133
Crebbptm1Few/Crebbptm1Few
(Not Specified)
increased liver glycogen level J:91133
Creg1em1Yal/Creg1em1Yal
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * DBA)
decreased susceptibility to hepatic steatosis J:263073
increased liver cholesterol level J:263073
increased liver free fatty acids level J:263073
increased liver weight J:263073
Cremtm1Saco/Cremtm1Saco
(involves: 129/Sv * C57BL/6)
decreased liver regeneration J:81370
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J)
abnormal hepatocyte morphology J:208708
Crim1em1(IMPC)Wtsi/Crim1em1(IMPC)Wtsi
(C57BL/6N-Crim1em1(IMPC)Wtsi/WtsiOrl)
herniated liver J:239583
Crkltm1Hkp/Crkltm1Hkp
(involves: 129S1/Sv * 129X1/SvJ)
abnormal liver morphology J:76680
Crtc2tm1.1Khk/Crtc2tm1.1Khk
(involves: C57BL/6 * C57BL/6J * FVB/N)
abnormal liver physiology J:151618
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased susceptibility to hepatic steatosis J:167211
Cry2tm1.1Yf/Cry2tm1.1Yf
Per2tm1Jt/Per2tm1Jt

(B6J.Cg-Cry2tm1.1Yf Per2tm1Jt)
abnormal liver physiology J:224319
Csf1op/Csf1op
(B6C3Fe a/a-Csf1op/J)
abnormal Kupffer cell morphology J:26978
Csf1op/Csf1op
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro

(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
liver inflammation J:117880
Csf1tm1.2Sabw/Csf1tm1.2Sabw
(involves: 129S4/SvJaeSor * C57BL/6)
abnormal Kupffer cell morphology J:180199
Csnk1a1tm1c(KOMP)Wtsi/Csnk1a1tm1c(KOMP)Wtsi
Tg(Mx1-cre)1Cgn/0

(involves: C57BL/6 * C57BL/6N * CBA)
abnormal liver morphology J:216977
abnormal liver physiology J:216977
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ)
hepatic steatosis J:184220
Ctbstm1Tbec/Ctbstm1Tbec
(involves: 129S2/SvPas * C57BL/6N)
abnormal Kupffer cell morphology J:185162
Cthtm1Iish/Cthtm1Iish
(B6.129-Cthtm1Iish)
abnormal liver morphology J:166184
Cthrc1tm1Vli/Cthrc1tm1Vli
(B6.Cg-Cthrc1tm1Vli)
abnormal hepatocyte morphology J:192096
hepatic steatosis J:192096
liver hypoplasia J:192096
Cthrc1tm1Vli/Cthrc1tm1Vli
(129S6.Cg-Cthrc1tm1Vli)
increased liver glycogen level J:192096
Ctla4tm1Saka/Ctla4tm1Saka
Foxp3tm1(cre)Saka/Y

(involves: BALB/c)
abnormal liver morphology J:140085
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocyte apoptosis J:71744
liver hemorrhage J:71744
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Mx1-cre)1Cgn/0

(involves: 129S1/Sv * C57BL/6 * CBA)
increased hepatoblastoma incidence J:112659
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Mx1-cre)1Cgn/0

(involves: 129S1/Sv * C57BL/6 * CBA)
increased hepatoblastoma incidence J:112659
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1+
Tg(CMV-cre)1Cgn/0

(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
increased hepatocyte apoptosis J:71744
liver hemorrhage J:71744
Ctsatm1Adz/Ctsatm1Adz
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/NJ))
enlarged liver J:29674
Ctsgtm2.1(PML/RARA)Ley/Ctsg+
(involves: 129X1/SvJ * C57BL/6)
enlarged liver J:84230
Ctslnkt/Ctslnkt
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2))
liver inflammation J:54856
Cul3tm1Jdsr/Cul3tm1Jdsr
(involves: 129S4/SvJaeSor)
abnormal liver morphology J:122228
increased liver weight J:122228
Cul4atm1.1Pra/Cul4atm1.1Pra
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * C57BL/6NTac * DBA)
decreased hepatocyte proliferation J:172043
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
increased liver tumor incidence J:170976
Cxcl12tm3.1(HBEGF/EGFP)Tng/Cxcl12+
(B6.Cg-Cxcl12tm3.1(HBEGF/EGFP)Tng)
hepatic necrosis J:164657
liver hemorrhage J:164657
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA)
decreased liver triglyceride level J:126841
decreased liver weight J:126841
Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
(involves: 129S2/SvPas * C57BL/6)
small liver J:113489
Cyb5atm1Wolf/Cyb5atm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * C57BL/6 * DBA)
liver/biliary system phenotype J:143097
Cybrd1tm1Nca/Cybrd1tm1Nca
(involves: 129S4/SvJae * 129S6/SvEvTac)
decreased liver iron level J:119528
increased liver weight J:119528
Cygbtm1Nka/Cygbtm1Nka
(B6.Cg-Cygbtm1Nka)
abnormal liver physiology J:174134
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn)
abnormal liver physiology J:88957
increased liver weight J:163973
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(involves: 129P2/OlaHsd * C57BL/6)
enlarged liver J:122409
Cyp1a1tm4.1Dwn/Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn)
increased liver weight J:163973
Cyp1a2tm1Dwn/Cyp1a2tm1Dwn
(B6.129P2-Cyp1a2tm1Dwn)
abnormal liver physiology J:88957
Cyp1a2tm1Gonz/Cyp1a2tm1Gonz
(involves: 129S4/SvJae)
liver/biliary system phenotype J:25724
Cyp2e1tm1Gonz/Cyp2e1tm1Gonz
(involves: 129S4/SvJae)
abnormal hepatocyte morphology J:118150
hepatic steatosis J:112076
Cyp7a1tm1Rus/Cyp7a1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J)
abnormal bile composition J:34870
abnormal liver morphology J:34342
abnormal liver physiology J:34342
Cyp8b1tm1Rus/Cyp8b1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J)
abnormal bile secretion J:100206
abnormal liver physiology J:100206, J:100246
Cyp11a1tm1b(EUCOMM)Hmgu/Cyp11a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp11a1tm1b(EUCOMM)Hmgu/Wtsi)
dilated bile duct J:239583
enlarged liver sinusoidal spaces J:239583
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J)
increased liver weight J:147610
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac)
enlarged liver J:65805
hepatic steatosis J:65805
pale liver J:65805
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal liver lobule morphology J:79603
abnormal liver physiology J:79603
hepatic steatosis J:79603, J:82070
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(involves: 129/Sv * C57BL/6J)
abnormal bile composition J:115373, J:48127
enlarged liver J:115373
increased liver triglyceride level J:115373
increased liver weight J:115373
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(B6.129-Cyp27a1tm1Elt/J)
enlarged liver J:223194
Cyp27a1tm1Elt/Cyp27a1tm1Elt
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg

(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
enlarged liver J:223194
Cys1cpk/Cys1+
(involves: C57BL/6J * CD-1)
liver cysts J:33739
liver fibrosis J:33739
Cys1cpk/Cys1+
(C.B6(Cg)-Cys1cpk)
liver cysts J:99616
liver fibrosis J:99616
Cys1cpk/Cys1cpk
(involves: C57BL/6J * CD-1)
biliary cyst J:33739
liver cysts J:33739
Cys1cpk/Cys1cpk
(C.B6(Cg)-Cys1cpk)
biliary cyst J:99616
dilated bile duct J:99616
liver fibrosis J:99616
Cys1cpk/Cys1cpk
(D2J.B6(Cg)-Cys1cpk)
abnormal bile duct morphology J:99620
liver fibrosis J:99620
Cys1cpk/Cys1cpk
(129.B6-Cys1cpk)
liver inflammation J:116210
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi)
abnormal liver physiology J:272118
decreased liver glycogen level J:272118
decreased liver triglyceride level J:272118
D930028M14Riktm1a(EUCOMM)Wtsi/D930028M14Riktm1a(EUCOMM)Wtsi
(C57BL/6N-D930028M14Riktm1a(EUCOMM)Wtsi/Wtsi)
herniated liver J:239583
Daglatm1a(EUCOMM)Wtsi/Daglatm1a(EUCOMM)Wtsi
(C57BL/6N-Daglatm1a(EUCOMM)Wtsi/Nju)
small liver J:211773
Daw1b2b1584Clo/Daw1b2b1584Clo
(C57BL/6J-Daw1b2b1584Clo)
abnormal liver morphology J:175213
Dbitm1Smdp/Dbitm1Smdp
(B6JBomTac.129-Dbitm1Smdp)
increased liver cholesterol level J:168744
increased liver triglyceride level J:168744
Dbitm1Smdp/Dbitm1Smdp
(involves: 129S1/Sv * 129X1/SvJ)
abnormal liver physiology J:204137
increased liver cholesterol level J:204137
increased liver triglyceride level J:204137
Dbitm2.1Smdp/Dbi+
Dbitm2.2Smdp/Dbi+
Tg(KRT14-cre)1Cgn/0

(involves: C57BL/6 * DBA/2 * FVB/N)
abnormal liver physiology J:204137
increased liver cholesterol level J:204137
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Wtsi)
enlarged liver sinusoidal spaces J:239583
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Teftm1Schb

(involves: 129P2/OlaHsd * 129S2/SvPas)
enlarged liver J:129710
Ddit3tm1.1Irt/Ddit3tm1.1Irt
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(Mup3-Plau)350-2Eps/?

(involves: C57BL/6 * DBA)
increased hepatocellular carcinoma incidence J:233146
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J)
hepatic steatosis J:214136
Ddrgk1tm1b(EUCOMM)Hmgu/Ddrgk1tm1b(EUCOMM)Hmgu
(involves: C57BL/6N)
liver hypoplasia J:231701
Ddx58tm1Aki/Ddx58tm1Aki
(Not Specified)
liver degeneration J:100539
Decr1tm1Jkh/Decr1tm1Jkh
(B6.129X1-Decr1tm1Jkh)
hepatic steatosis J:151622
increased liver weight J:151622
pale liver J:151622
Deddtm1Tmiy/Deddtm1Tmiy
(B6.Cg-Deddtm1Tmiy)
decreased liver weight J:119734
Degs1Gt(OST368559)Lex/Degs1Gt(OST368559)Lex
(involves: 129S5/SvEvBrd)
decreased liver function J:203554
Del(1)1Brk/Steap3tm1.1Mdf
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)
increased liver iron level J:103440
Del(1)1Brk/Del(1)1Brk
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
abnormal liver iron level J:100202
enlarged liver J:100202
Del(1)1Brk/Del(1)1Brk
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)
increased liver iron level J:103440
Del(4C4-C5)1Lap/+
(involves: 129S6/SvEvTac)
enlarged liver J:158126
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac)
enlarged liver J:158126
Del(5Gtf2i-Fkbp6)1Vcam/+
(B6.129-Del(5Gtf2i-Fkbp6)1Vcam(J:204278))
hepatic steatosis J:216195
Del(6Slco1b2-Slco1a5)1Nki/+
(involves: 129P2/OlaHsd * C57BL/6)
abnormal bile secretion J:163765
jaundice J:163765
Del(7Cyp2s1-Cyp2a5)1Ding/Del(7Cyp2s1-Cyp2a5)1Ding
(involves: BALB/cJ * C57BL/6)
abnormal liver physiology J:190445
Del(9Cyp1a2-Cyp1a1)1Dwn/Del(9Cyp1a2-Cyp1a1)1Dwn
Tg(CYP1A1,CYP1A2)1Dwn/Tg(CYP1A1,CYP1A2)1Dwn

(B6.Cg-Del(9Cyp1a2-Cyp1a1)1Dwn Tg(CYP1A1,CYP1A2)1Dwn)
enlarged liver J:122409
Del(11Hoxb3-Hoxb4)1Karl/Del(11Hoxb3-Hoxb4)1Karl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal liver morphology J:83563
Del(11Irf1-D11Mit23)1Rub/Del(11Irf1-D11Mit23)1Rub
(129/Sv-Del(11Irf1-D11Mit23)1Rub)
enlarged liver J:60187
hepatic steatosis J:60187
increased liver triglyceride level J:60187
increased liver weight J:60187
pale liver J:60187
Del(11Jmjd6-Mettl23)1Ysfk/Del(11Jmjd6-Mettl23)1Ysfk
(involves: C57BL/6)
liver hypoplasia J:90288
Del(16Lipi-Usp25)1Dja/+
(involves: 129P2/OlaHsd * C57BL/6)
hepatic steatosis J:184302
Del(17Abcg5-Abcg8)1Hobb/Del(17Abcg5-Abcg8)1Hobb
(involves: 129S6/SvEvTac * C57BL/6)
abnormal bile composition J:80679
Dennd1aem1Jgfu/Dennd1aem1Jgfu
(Not Specified)
abnormal cholangiocyte morphology J:276703
abnormal liver development J:276703
decreased hepatocyte proliferation J:276703
pale liver J:276703
small liver J:276703
Dennd5bem1Smgo/Dennd5bem1Smgo
(involves: C57BL/6 * CBA)
decreased liver cholesterol level J:276600
decreased liver free fatty acids level J:276600
Deptortm1.1Mala/Deptortm1.1Mala
Speer6-ps1Tg(Alb-cre)21Mgn/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 x DBA)
decreased liver glycogen level J:275931
liver/biliary system phenotype J:275931
Derl2tm1.1Hpl/Derl2tm1.1Hpl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * DBA)
liver/biliary system phenotype J:170650
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J)
decreased liver cholesterol level J:111346
decreased liver triglyceride level J:111346
decreased susceptibility to hepatic steatosis J:111346
Dhcr7tm1Gst/Dhcr7tm1Gst
(involves: 129P2/OlaHsd)
decreased liver cholesterol level J:71611
Dhcr7tm1Gst/Dhcr7tm1Gst
Tg(APOE-DHCR7)2Hoyu/0

(involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N)
decreased liver cholesterol level J:141730
Dhfrorana/Dhfrorana
(involves: C57BL/6JAnu)
liver hypoplasia J:236197
pale liver J:236197
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6)
increased liver glycogen level J:267178
Dhx36tm1.2Pmt/Dhx36tm1.2Pmt
Commd10Tg(Vav1-icre)A2Kio/Commd10+

(involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * C57BL/10 * CBA/Ca)
enlarged liver J:185179
pale liver J:185179
Dicer1tm1Bdh/Dicer1tm1Bdh
Foxp3tm4(YFP/icre)Ayr/Y

(involves: 129S1/Sv * 129X1/SvJ)
liver inflammation J:138683
Dicer1tm1Bdh/Dicer1tm1Bdh
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr

(involves: 129S1/Sv * 129X1/SvJ)
liver inflammation J:138683
Dicer1tm1Bdh/Dicer1tm1Bdh
Tg(Foxp3-EGFP/icre)1aJbs/0

(involves: 129 * NOD/ShiLt)
liver inflammation J:138808
Dicer1tm1Gz/Dicer1tm1Gz
(involves: 129P2/OlaHsd * C57BL/6)
small liver J:97770
Dio3tm1Dmst/Dio3tm1Dmst
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * DBA)
increased hepatocyte proliferation J:218350
liver/biliary system phenotype J:218350
Dlk1tm1Hsul/Dlk1tm1Hsul
(either: (involves: 129 * BALB/c) or (involves: 129 * C57BL/6J))
enlarged liver J:77909
hepatic steatosis J:77909
Dmdmdx-3Cv/Y
Utrntm1Ked/Utrntm1Ked

(involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m musculus)
liver/biliary system phenotype J:116348
Dmdmdx-3Cv/Dmdmdx-3Cv
Utrntm1Ked/Utrntm1Ked

(involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m musculus)
liver/biliary system phenotype J:116348
Dmtf1tm1Cjs/Dmtf1+
Krastm2Tyj/Kras+

(involves: 129S2/SvPas * C57BL/6)
increased cholangiocarcinoma incidence J:126002
Dna2tm1.1Lzhg/Dna2+
(involves: 129S1/Sv)
increased hepatoma incidence J:198831
Dnaaf3b2b1739Clo/Dnaaf3b2b1739Clo
(C57BL/6J-Dnaaf3b2b1739Clo)
abnormal liver morphology J:175213
Dnah5b2b016Clo/Dnah5b2b016Clo
(C57BL/6J-Dnah5b2b016Clo)
abnormal liver morphology J:175213
Dnah5hlb612/Dnah5hlb612
(involves: C57BL/6J)
abnormal liver morphology J:130755
Dnah11b2b1289Clo/Dnah11b2b1289Clo
(C57BL/6J-Dnah11b2b1289Clo)
abnormal liver morphology J:175213
Dnah11b2b1775Clo/Dnah11b2b1775Clo
(C57BL/6J-Dnah11b2b1775Clo)
abnormal biliary tract morphology J:175213
Dnah11iv/Dnah11iv
(SI/Col Tyrp1b Dnah11iv/J)
abnormal liver morphology J:148465, J:4058
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(129P2/OlaHsd-Dnajb9Gt(KST256)Byg)
decreased liver glycogen level J:226674
decreased liver weight J:226674
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg)
decreased liver glycogen level J:226674
decreased liver weight J:226674
Dnajc7tm1.2Neg/Dnajc7tm1.2Neg
(involves: 129S/SvEv * C57BL/6 * CBA)
hepatic steatosis J:225381
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg)
decreased liver cholesterol level J:204025
decreased susceptibility to hepatic steatosis J:204025
increased liver glycogen level J:204025
increased liver weight J:204025
Dnm1lPy/Dnm1l+
(involves: BALB/cAnNCrl * C3H/HeH)
liver vascular congestion J:161510
Dnm1ltm1.2Miha/Dnm1ltm1.2Miha
(involves: C57BL/6J)
delayed hepatic development J:158142
Dnmt3btm1Enl/Dnmt3btm1Enl
(involves: 129S4/SvJae * C57BL/6)
small liver J:106540
Dohhtm1.1Sbal/Dohhtm1.1Sbal
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
focal hepatic necrosis J:236582
hepatic necrosis J:236582
Dph1tm2Bhr/Dph1tm2Bhr
(either: 129/Sv or (involves: 129/Sv * C57BL/6))
abnormal hepatoblast morphology J:88090
liver degeneration J:88090
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low/J)
decreased liver weight J:106832
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Y

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
liver inflammation J:138683
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
liver inflammation J:138683
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0

(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
liver inflammation J:138683
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl)
liver inflammation J:151605
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
decreased liver weight J:129718
decreased susceptibility to hepatic steatosis J:129718
small liver J:129718
Dusp26em1Jhxia/Dusp26em1Jhxia
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * DBA)
abnormal liver morphology J:279111
decreased liver glycogen level J:279111
increased liver cholesterol level J:279111
increased liver free fatty acids level J:279111
increased liver triglyceride level J:279111
increased liver weight J:279111
liver fibrosis J:279111
Dyrk1atm1Mla/Dyrk1a+
(involves: 129P2/OlaHsd * C57BL/6)
decreased liver weight J:78597
Dzip1lwarpy/Dzip1lwarpy
(involves: C57BL/6 * CD-1)
bile duct proliferation J:249936
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
liver inflammation J:76318
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J)
increased hepatocellular carcinoma incidence J:145228
Ebf1tm1Rug/Ebf1tm1Rug
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
hepatic steatosis J:147179
Efemp1tm2Lmar/Efemp1tm2Lmar
(involves: 129X1/SvJ * C57BL/6)
decreased liver weight J:132043
liver degeneration J:132043
Efstm1Kale/Efstm1Kale
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))
liver inflammation J:103757
Egfrtm1Mag/Egfrtm1Mag
(involves: 129S2/SvPas * CD-1)
abnormal hepatocyte morphology J:26833
abnormal liver morphology J:26833
Egfrtm1Msi/Egfrtm1Msi
Tg(Alb1-cre)7Gsc/?

(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
decreased liver regeneration J:125912
Egfrtm1Msi/Egfrtm1Msi
Tg(Mx1-cre)1Cgn/?

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
decreased liver regeneration J:125912
Egln1tm1Kael/Egln1tm1Kael
Tg(Myh6-cre)2182Mds/0

(involves: 129S6/SvEvTac * FVB/N)
liver vascular congestion J:179490
Egln1tm2.1Fsl/Egln1tm2.1Fsl
Pax3tm1(cre)Joe/Pax3+

(involves: 129 * C57BL/6)
abnormal liver vasculature morphology J:202737
increased liver weight J:202737
Egln1tm2Fong/Egln1tm2Fong
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+

(involves: 129S6/SvEvTac * C57BL/6)
abnormal liver morphology J:132720
enlarged liver J:132720
enlarged liver sinusoidal spaces J:133568
Egln2tm1Fong/Egln2tm1Fong
Egln3tm1Fong/Egln3tm1Fong

(involves: 129S6/SvEvTac * C57BL/6)
enlarged liver J:132720
Egr1tm1Jmi/Egr1tm1Jmi
(B6.129-Egr1tm1Jmi)
abnormal liver physiology J:128421
liver inflammation J:128421
liver/biliary system phenotype J:128421
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
abnormal liver physiology J:105638
abnormal liver size J:105638
decreased liver regeneration J:93996
increased liver triglyceride level J:105638
liver/biliary system phenotype J:105638
Ehbp1l1tm1a(EUCOMM)Wtsi/Ehbp1l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ehbp1l1tm1a(EUCOMM)Wtsi/Wtsi)
abnormal bile duct morphology J:239583
abnormal cystic duct morphology J:239583
enlarged liver sinusoidal spaces J:239583
Ehhadhtm1Jkr/Ehhadhtm1Jkr
Hsd17b4tm1Baes/Hsd17b4tm1Baes

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
hepatic steatosis J:89945
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Tg(Adipoq-cre)1Evdr/0

(involves: 129P2/OlaHsd * FVB/NJ)
abnormal liver morphology J:207678
increased liver triglyceride level J:207678
Ei24tm1Hzha/Ei24tm1Hzha
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
abnormal hepatocyte morphology J:193420
abnormal liver lobule morphology J:193420
abnormal liver morphology J:193420
enlarged liver J:193420
Eif2ak3tm1Drc/Eif2ak3tm1Drc
(involves: 129S6/SvEvTac)
increased liver glycogen level J:76661
Eif2ak4tm1Drc/Eif2ak4tm1Drc
(involves: 129S6/SvEvTac * C57BL/6)
decreased liver weight J:92545
Eif2ak4tm1Drc/Eif2ak4tm1Drc
(B6.129S6-Eif2ak4tm1Drc)
decreased liver weight J:92545
Eif3etm1Fshb/Eif3e+
(C57BL/6N-Eif3etm1Fshb)
small liver J:265010
Eif3mtm1.1Nju/Eif3m+
(involves: 129 * FVB/N)
decreased liver weight J:204915
liver/biliary system phenotype J:204915
Eif3mtm1Nju/Eif3mtm1Nju
(involves: 129)
abnormal liver morphology J:204915
Eif6tm1Sbif/Eif6+
(involves: 129 * C57BL/6)
abnormal hepatocyte physiology J:141257
decreased liver weight J:141257
liver hypoplasia J:141257
Eloatm1Aso/Eloatm1Aso
(involves: 129S/SvEv * C57BL/6)
delayed hepatic development J:119126
Elovl5Gt(DTM098)Byg/Elovl5Gt(DTM098)Byg
(involves: 129P2/OlaHsd * C57BL/6)
abnormal liver physiology J:149093
hepatic steatosis J:149093
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
abnormal hepatocyte physiology J:130031
abnormal liver morphology J:130031
hepatic steatosis J:130031
Embtm1b(KOMP)Wtsi/Emb+
(C57BL/6N-Embtm1b(KOMP)Wtsi/Ucd)
abnormal liver morphology J:211773
Enhotm1.1Butl/Enho+
(B6.Cg-Enhotm1.1Butl)
hepatic steatosis J:225402
increased liver triglyceride level J:225402
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl)
hepatic steatosis J:225402
increased liver triglyceride level J:225402
Enkurtm1Hmf/Enkurtm1Hmf
(involves: 129 * C57BL/6J)
abnormal liver development J:253966
abnormal liver morphology J:253966
Enpp1asj/Enpp1asj
(C57BL/6J-Enpp1asj/GrsrJ)
abnormal liver vasculature morphology J:201689
Entpd1tm1Rdr/Entpd1tm1Rdr
(involves: 129S2/SvPas)
liver fibrosis J:57505
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
abnormal hepatocyte morphology J:163795
abnormal Kupffer cell morphology J:163795
abnormal oval cell morphology J:163795
abnormal oval cell physiology J:163795
enlarged liver J:163795
increased hepatocellular carcinoma incidence J:163795
increased hepatocyte apoptosis J:163795
increased hepatocyte proliferation J:163795
increased liver adenoma incidence J:163795
liver inflammation J:163795
Epas1tm1Rus/Epas1tm1Rus
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
liver vascular congestion J:50964
Epb41tm1Cnby/Epb41tm1Cnby
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)
increased liver iron level J:77852
Epg5tm1Ygz/Epg5tm1Ygz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
liver/biliary system phenotype J:196603
Epha3tm1Abn/Epha3tm1Abn
(involves: 129S1/Sv * 129S1/SvImJ)
liver vascular congestion J:119874
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J)
hepatic steatosis J:173769
increased liver cholesterol level J:173769
increased liver triglyceride level J:173769
Epm2aip1Gt(BA0314)Wtsi/Epm2aip1Gt(BA0314)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
decreased liver glycogen level J:204966
hepatic steatosis J:204966
Epotm1.2Mym/Epotm1.2Mym
(Not Specified)
abnormal liver morphology J:175070
abnormal liver physiology J:175070
pale liver J:175070
small liver J:175070
Epotm1Jae/Epotm1Jae
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
increased hepatocyte apoptosis J:29254
pale liver J:29254
small liver J:29254
Eportm1Cos/Eportm1Cos
(involves: 129S/SvEv * C57BL/6J)
pale liver J:31156
small liver J:31156
Eportm1Jae/Epor+
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
pale liver J:29254
Eportm1Jae/Eportm1Jae
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
increased hepatocyte apoptosis J:29254
pale liver J:29254
small liver J:29254
Eportm1Lizon/Eportm1Lizon
(involves: 129S4/SvJae * C57BL/6)
increased hepatocyte apoptosis J:35594
liver hypoplasia J:35594
pale liver J:35594
small liver J:35594
Ercc1tm1Dwm/Ercc1+
(involves: 129P2/OlaHsd * BALB/c)
abnormal liver physiology J:15422
decreased liver function J:15422
Ercc1tm1Dwm/Ercc1tm1Dwm
(involves: 129P2/OlaHsd * BALB/c)
decreased liver function J:15422
liver degeneration J:15422
Ercc1tm1Dwm/Ercc1tm2Dwm
Hrhr/Hrhr
Tg(KRT5-cre)5132Jlj/0

(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J * MF1)
abnormal hepatocyte morphology J:115849
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: C57BL/6 * FVB/N)
abnormal liver physiology J:92471
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
decreased hepatocyte proliferation J:117488
hepatic steatosis J:117488
increased hepatocyte apoptosis J:117488
increased liver triglyceride level J:117488
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
abnormal hepatocyte morphology J:206925
Ercc1tm1Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
abnormal hepatocyte morphology J:206925
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hepatocyte morphology J:41161
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
abnormal hepatocyte morphology J:206925
Ercc4tm1Fwa/Ercc4tm1Fwa
(involves: 129S6/SvEvTac)
abnormal liver morphology J:87684
increased hepatocyte karyomegaly J:87684
Ercc5tm1Shm/Ercc5tm1Shm
(involves: 129S2/SvPas * C57BL/6J)
abnormal hepatocyte morphology J:53756
small liver J:53756
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Hvs/Xpatm1Hvs

(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh)
hepatic steatosis J:122013
increased liver glycogen level J:122013
Erfetm1Lex/Erfe+
(B6;129S5-Erfetm1Lex/Mmucd)
abnormal liver physiology J:211331
Erfetm1Lex/Erfetm1Lex
(B6;129S5-Erfetm1Lex/Mmucd)
abnormal liver physiology J:211331
Erfetm1Lex/Erfetm1Lex
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+

(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
decreased liver iron level J:211331
Ern1tm1Rjk/Ern1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
liver hypoplasia J:106975
Ern1tm1Rjk/Ern1tm2.1Rjk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
abnormal hepatocyte morphology J:171230
hepatic steatosis J:171230
increased hepatocyte apoptosis J:171230
increased liver triglyceride level J:171230
Ern1tm2.1Tiw/Ern1tm2.2Tiw
Meox2tm1(cre)Sor/Meox2+

(involves: 129S4/SvJae * C57BL/6)
liver/biliary system phenotype J:153222
Errfi1tm1Gvw/Errfi1tm1Gvw
(Not Specified)
liver/biliary system phenotype J:100927
Espl1tm1.1Kna/Espl1tm1.1Kna
Tg(Mx1-cre)1Cgn/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
abnormal hepatocyte morphology J:107916
abnormal liver regeneration J:107916
Esr1tm1Ksk/Esr1tm1Ksk
Inhatm1Bay/Inhatm1Bay

(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)
abnormal hepatocyte morphology J:84989
hepatic necrosis J:84989
liver inflammation J:84989
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
enlarged liver J:83617
Esr2tm1Unc/Esr2tm1Unc
Inhatm1Bay/Inhatm1Bay

(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)
abnormal liver morphology J:84989
Esrp2tm1(KOMP)Vlcg/Esrp2tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
abnormal hepatocyte morphology J:228040
abnormal liver development J:228040
abnormal liver morphology J:228040
increased hepatocyte proliferation J:228040
Exoc3l2tm1b(KOMP)Wtsi/Exoc3l2tm1b(KOMP)Wtsi
(C57BL/6N-Exoc3l2tm1b(KOMP)Wtsi/Wtsi)
enlarged liver sinusoidal spaces J:239583
herniated liver J:239583
F2rtm1Ajc/F2rtm1Ajc
(involves: 129S4/SvJae * C57BL/6)
abnormal gallbladder physiology J:123689
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6)
abnormal gallbladder physiology J:123689
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd)
liver inflammation J:102762
F5tm2Dgi/F5tm2Dgi
(B6.129S2-F5tm2Dgi)
liver fibrosis J:66260
F9tm1Emg/Y
(involves: 129S/SvEv * C57BL/6J)
liver/biliary system phenotype J:48501
F11tm1Gjb/F11tm1Gjb
Proctm1Fjc/Proctm1Fjc

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal liver morphology J:67398
hepatic necrosis J:67398
liver fibrosis J:67398
liver hemorrhage J:67398
Fabp1tm1Bin/Fabp1tm1Bin
(involves: 129/Ola * C57BL/6)
abnormal hepatobiliary system physiology J:83875
Fabp1tm1Ddsn/Fabp1tm1Ddsn
(involves: 129X1/SvJ * C57BL/6)
decreased liver triglyceride level J:87278
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto)
decreased liver weight J:64975
increased liver weight J:64975
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
decreased liver glycogen level J:167535
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob

(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob)
decreased liver triglyceride level J:111878
decreased susceptibility to hepatic steatosis J:111878
small liver J:111878
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota)
decreased liver weight J:81609
Fabp6tm1Lbal/Fabp6tm1Lbal
(B6.129-Fabp6tm1Lbal)
decreased liver cholesterol level J:195544
decreased liver weight J:195544
Faddtm1Mpa/Faddtm1Mpa
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0

(involves: C57BL/6 * FVB/N)
liver inflammation J:118336
liver/biliary system phenotype J:118336
Fads2tm1Mtna/Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J)
enlarged liver J:153293
increased liver triglyceride level J:153293
increased liver weight J:153293
Fads3tm1a(KOMP)Wtsi/Fads3tm1a(KOMP)Wtsi
(C57BL/6-Fads3tm1a(KOMP)Wtsi)
decreased liver free fatty acids level J:256005
increased liver free fatty acids level J:256005
Faf2tm1Tfji/Faf2tm1Tfji
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * C57BL/6N * CBA * DBA)
hepatic steatosis J:235325
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * PT)
abnormal liver physiology J:77295
jaundice J:77295
pale liver J:77295
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL/6)
abnormal hepatocyte morphology J:138701
abnormal liver physiology J:138701
abnormal liver regeneration J:138701
decreased hepatocyte proliferation J:138701
decreased liver regeneration J:138701
increased hepatocellular carcinoma incidence J:138701
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd)
decreased hepatocyte apoptosis J:105440
liver failure J:105440
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL)
abnormal hepatocyte morphology J:27735
abnormal hepatocyte physiology J:27735
abnormal liver lobule morphology J:27735
increased hepatocellular carcinoma incidence J:27735
increased hepatoma incidence J:27735
increased liver adenoma incidence J:27735
increased liver tumor incidence J:27735
liver inflammation J:27735
liver/biliary system phenotype J:27735
Fahtm1Mgo/Fahtm1Mgo
Hgdaku/Hgd+

(involves: 129S7/SvEvBrd * NB)
abnormal hepatocyte morphology J:77295
abnormal liver morphology J:77295
abnormal liver physiology J:77295
jaundice J:77295
pale liver J:77295
Fahtm1Mgo/Fahtm1Mgo
Hgdaku/Hgdaku

(involves: 129S7/SvEvBrd * NB)
liver/biliary system phenotype J:77295
Faimtm1Kplm/Faimtm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
increased hepatocyte apoptosis J:164184
liver failure J:164184
liver hemorrhage J:164184
liver inflammation J:164184
Fam20bGt(GST_4283_D8)Lex/Fam20bGt(GST_4283_D8)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
delayed hepatic development J:186384
Fan1tm1d(KOMP)Wtsi/Fan1tm1d(KOMP)Wtsi
(involves: C57BL/6N * FVB/N)
decreased liver function J:232402
increased hepatocyte karyomegaly J:232402
Fancctm1Mab/Fancctm1Mab
Sod1tm1Cep/Sod1tm1Cep

(involves: 129S1/Sv * 129X1/SvJ)
abnormal hepatocyte physiology J:71134
hepatic steatosis J:71134
pale liver J:71134
Fancmtm1.1Htr/Fancmtm1.1Htr
(involves: C57BL/6 * FVB)
increased hepatoma incidence J:151714
Faslpr/Fas+
Tg(TcraTcrb)1100Mjb/?

(involves: C57BL/6 * MRL/Mp)
liver inflammation J:72817
liver/biliary system phenotype J:72817
Faslpr/Faslpr
(B6.MRL-Faslpr/J)
abnormal hepatocyte morphology J:135830
abnormal liver physiology J:120559, J:135830
decreased hepatocyte apoptosis J:135830
focal hepatic necrosis J:135830
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0

(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp)
liver inflammation J:122222
Faslpr/Faslpr
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl

(involves: 129/Sv * C57BL/6)
liver inflammation J:92470
Fastm1Ach/Fastm1Ach
Tg(Itgax-cre,-EGFP)4097Ach/?

(Not Specified)
abnormal liver morphology J:123556
Fastm1Cgn/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0

(B6.Cg-Fastm1Cgn Tg(Cd4-cre)1Cwi)
liver inflammation J:114948
Fastm1Osa/Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hepatocyte morphology J:64296
liver hyperplasia J:64296
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J)
abnormal hepatocyte morphology J:135830
decreased hepatocyte apoptosis J:135830
focal hepatic necrosis J:135830
liver inflammation J:135830
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6)
increased liver tumor incidence J:153501
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6)
enlarged liver J:87990
Fasntm1Sem/Fasntm1Sem
Speer6-ps1Tg(Alb-cre)21Mgn/?

(involves: 129X1/SvJ * C57BL/6 * DBA)
decreased liver cholesterol level J:127793
hepatic steatosis J:127793
increased liver weight J:127793
Fbxl5Gt(OST386421)Lex/Fbxl5+
(involves: 129S5/SvEvBrd * C57BL/6)
decreased liver iron level J:193752
Fbxl5tm1Kei/Fbxl5tm1Kei
Ireb2tm1Roua/Ireb2tm1Roua

(B6.Cg-Fbxl5tm1Kei Ireb2tm1Roua)
decreased liver iron level J:176655
Fbxl5tm2.1Kei/Fbxl5tm2.1Kei
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * DBA)
abnormal hepatocyte morphology J:176655
abnormal liver physiology J:176655
hepatic steatosis J:176655
increased liver iron level J:176655
liver failure J:176655
liver hemorrhage J:176655
liver inflammation J:176655
pale liver J:176655
Fbxo4tm1.1Jadi/Fbxo4+
(Not Specified)
increased hepatic hemangioma incidence J:178645
increased hepatocellular carcinoma incidence J:178645
Fbxo4tm1.1Jadi/Fbxo4tm1.1Jadi
(Not Specified)
increased hepatic hemangioma incidence J:178645
increased hepatocellular carcinoma incidence J:178645
Fbxw7tm1Iken/Fbxw7+
Krastm4Tyj/Kras+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S4/SvJae * C57BL/6 * C57BL/6N * DBA)
bile duct hyperplasia J:258194
dilated bile duct J:258194
Fbxw7tm1Iken/Fbxw7tm1Iken
Krastm4Tyj/Kras+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S4/SvJae * C57BL/6 * C57BL/6N * DBA)
increased cholangiocarcinoma incidence J:258194
Fbxw7tm1Iken/Fbxw7tm1Iken
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * C57BL/6N * DBA)
bile duct hyperplasia J:258194
dilated bile duct J:258194
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk)
liver inflammation J:64152
Fechm1Pas/Fechm1Pas
(involves: 129/Sv * BALB/c)
increased liver weight J:2021
jaundice J:2021
Fechm1Pas/Fechm1Pas
hem6/hem6+

(involves: 129 * BALB/c * C57BL/6)
increased liver weight J:142791
Fechm1Pas/Fechtm1.1(FECH*)Emi
(involves: 129 * BALB/cJ * C57BL/6J)
abnormal bile canaliculus morphology J:239515
abnormal liver morphology J:239515
enlarged liver J:239515
jaundice J:239515
Fen1tm1Bhsh/Fen1tm1Bhsh
(involves: 129S1/Sv)
pale liver J:121378
Fen1tm2.1Bhsh/Fen1tm2.1Bhsh
(involves: 129S1/Sv)
increased liver tumor incidence J:218627
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified)
increased liver tumor incidence J:231218
Festm2Mcs/Fes+
(chimera involves: 129X1/SvJ * C57BL/6)
liver hemorrhage J:76509
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
increased liver triglyceride level J:141957
Ffar1tm1Heed/Ffar1tm1Heed
(Not Specified)
decreased susceptibility to hepatic steatosis J:129843
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6)
hepatic steatosis J:182599
increased liver triglyceride level J:182599
increased liver weight J:182599
Fgatm1Jld/Fgatm1Jld
(involves: 129P2/OlaHsd * CF-1)
focal hepatic necrosis J:36591
liver hemorrhage J:28436
Fgatm1Jld/Fgatm1Jld
(B6.129P2-Fgatm1Jld)
liver hemorrhage J:28436
Fgatm1Jld/Fgatm1Jld
Plgtm1Jld/Plgtm1Jld

(involves: 129P2/OlaHsd * Black Swiss * CF-1)
abnormal liver morphology J:36591
focal hepatic necrosis J:36591
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf)
abnormal liver physiology J:157309
hepatic steatosis J:157309
increased liver glycogen level J:157309
increased liver triglyceride level J:157309
increased liver weight J:157309
Fgf21tm1Nit/Fgf21tm1Nit
(C57BL/6-Fgf21tm1Nit)
increased liver weight J:157334
Fgfr2tm2.3Dsn/Fgfr2+
(involves: 129 * C57BL/6 * FVB/N)
abnormal liver development J:72517
Fgfr4tm1Cxd/Fgfr4tm1Cxd
Tg(Myl2-FGF19)1Dfre/0

(involves: 129S6/SvEvTac * FVB/N)
decreased liver tumor incidence J:187236
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
abnormal liver weight J:199844
hepatic steatosis J:199844
increased liver triglyceride level J:199844
Fhittm1Tko/Fhittm1Tko
(involves: 129X1/SvJ)
increased hepatocellular carcinoma incidence J:93269
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Tg(Fabp4-cre)1Rev/?

(involves: 129S6/SvEvTac * C57BL/6J)
increased liver weight J:212437
pale liver J:212437
Fkbp1atm1Zuk/Fkbp1atm1Zuk
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
hepatic necrosis J:45536
liver hemorrhage J:45536
Fl1saA/J/?
(involves: A/JSlc * SM/JNshm)
increased liver triglyceride level J:124974
increased liver weight J:124974
Fl1saSM/JNshm/Fl1saSM/JNshm
(A/J-Chr 12SM/J/Nshm)
decreased liver triglyceride level J:124974
decreased liver weight J:124974
decreased susceptibility to hepatic steatosis J:124974
Fl2saA/JNshm/Fl2saA/JNshm
(involves: A/JSlc * SM/JNshm)
increased liver weight J:124974
Fli1tm1Dkw/Fli1tm1Dkw
(either: B6.Cg-Fli1tm1Dkw or (involves: CD-1) or (involves: 129S6/SvEvTac * C57BL/6))
pale liver J:63242
small liver J:63242
Flnatm1.2Caw/Flna+
(involves: 129S4/SvJae * C57BL/6)
hepatic necrosis J:118252
Flt4Chy/Flt4+
(involves: C3H)
abnormal liver morphology J:72387
fm/fm
(involves: CBA/H)
abnormal liver morphology J:275, J:5417
Fmnl1tm1.2Sdb/Fmnl1tm1.2Sdb
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo

(involves: C3H * C57BL/6 * FVB/N)
abnormal Kupffer cell morphology J:250144
Fn1tm1.1Sakai/Fn1tm1.1Sakai
Tg(Mx1-cre)1Cgn/0

(involves: C57BL/6 * CBA)
abnormal liver physiology J:214945
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
increased liver glycogen level J:187318
Fosl1tm2Wag/Fosl1tm2Wag
Meox2tm1(cre)Sor/Meox2+

(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
liver/biliary system phenotype J:213764
Foxa1tm1Khk/Foxa1tm1Khk
Foxa2tm1Khk/Foxa2tm1Khk
Tg(Alb1-cre)1Khk/0

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
increased hepatocellular carcinoma incidence J:181296
Foxa2tm1Dnl/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6J)
increased liver triglyceride level J:95662
Foxc1tm1Blh/Foxc1+
Foxc2tm1Blh/Foxc2+

(involves: 129S6/SvEvTac * Black Swiss)
enlarged liver J:57677
Foxm1tm1.1Rhc/Foxm1tm1.1Rhc
(involves: 129X1/SvJ)
abnormal hepatic cord morphology J:94883
abnormal hepatoblast morphology J:94883
abnormal intrahepatic bile duct morphology J:94883
abnormal liver sinusoid morphology J:94883
decreased hepatoblast number J:94883
Foxm1tm1Cle/Foxm1tm1Cle
(Not Specified)
abnormal hepatocyte morphology J:95612
Foxm1tm1Rhc/Foxm1tm1Rhc
(involves: 129X1/SvJ)
increased hepatocellular carcinoma incidence J:89472
Foxm1tm1Rhc/Foxm1tm1Rhc
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129X1/SvJ * C57BL/6 * DBA)
abnormal hepatocyte morphology J:89472, J:81015
abnormal liver regeneration J:81015
decreased liver tumor incidence J:89472
Foxm1tm1Rhc/Foxm1tm1Rhc
Tg(Alb1-cre)1Khk/0

(involves: 129X1/SvJ * C57BL/6 * SJL)
abnormal hepatic cord morphology J:94883
abnormal hepatoblast morphology J:94883
abnormal intrahepatic bile duct morphology J:94883
abnormal liver sinusoid morphology J:94883
decreased hepatoblast number J:94883
Foxn1nu/Foxn1nu
(Not Specified)
abnormal liver morphology J:5043
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo3tm1Rdp/Foxo3tm1Rdp
Tg(Mx1-cre)1Cgn/0

(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
increased hepatic hemangioma incidence J:118179
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo4tm1Rdp/Foxo4tm1Rdp
Tg(Mx1-cre)1Cgn/0

(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
increased hepatic hemangioma incidence J:118179
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified)
decreased liver triglyceride level J:179687
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(B6.Cg-Foxo1tm2.1Dac)
decreased liver cholesterol level J:179687
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg)
abnormal Kupffer cell morphology J:236585
decreased liver triglyceride level J:236585
decreased susceptibility to hepatic steatosis J:236585
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))
abnormal hepatic cord morphology J:11262
abnormal liver morphology J:11262
enlarged liver J:11262
enlarged liver sinusoidal spaces J:11262
jaundice J:11262
liver inflammation J:11262
multifocal hepatic necrosis J:11262
Foxp3sf/Y
(involves: 101/H * C3H/HeH * STOCK MR)
abnormal liver morphology J:10398
enlarged liver J:10398
pale liver J:10398
Foxp3sf/?
(Not Specified)
liver inflammation J:138808
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
liver inflammation J:117743
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
liver inflammation J:117743
Foxp3tm3(DTR/GFP)Ayr/Foxp3tm3(DTR/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
liver inflammation J:117743
fpw/fpw
(involves: C3H/HeJ * C57BL/6J)
decreased hepatocyte proliferation J:151726
Frem1eyes2/Frem1eyes2
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal gallbladder morphology J:192553
Fstl3tm1.1(KOMP)Vlcg/Fstl3tm1.1(KOMP)Vlcg
(C57BL/6N-Fstl3tm1.1(KOMP)Vlcg/Ucd)
abnormal liver morphology J:211773
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
hepatic steatosis J:119526
liver/biliary system phenotype J:119526
Fth1tm1.1Lck/Fth1tm1.1Lck
Tg(Mx1-cre)1Cgn/0

(B6.Cg-Fth1tm1.1Lck Tg(Mx1-cre)1Cgn)
hepatic steatosis J:166515
increased liver weight J:166515
liver hemorrhage J:166515
liver inflammation J:166515
Ftl1tm1.1Ruvi/Ftl1tm1.1Ruvi
(involves: 129 * C57BL/6)
decreased liver iron level J:244236
Ftotm1Urt/Ftotm1Urt
Lepob/Lepob

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
hepatic steatosis J:219118
increased liver weight J:219118
Fubp1tm1.1Dlev/Fubp1tm1.1Dlev
(involves: 129 * C57BL/6)
pale liver J:229985
small liver J:229985
Furintm1Jwmc/Furintm1.1Jwmc
Tg(Mx1-cre)1Cgn/0

(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * C57BL/6J * CBA)
liver/biliary system phenotype J:118515
Fut8em1(IMPC)Wtsi/Fut8em1(IMPC)Wtsi
(C57BL/6N-Fut8em1(IMPC)Wtsi/Wtsi)
enlarged liver sinusoidal spaces J:239583
Fuzb2b1273Clo/Fuzb2b1273Clo
(C57BL/6J-Fuzb2b1273Clo)
abnormal liver morphology J:175213
Fzr1tm1.1Mama/Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL)
increased liver tumor incidence J:137456
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
abnormal liver morphology J:209000
decreased liver triglyceride level J:209000
decreased liver weight J:209000
decreased susceptibility to hepatic steatosis J:209000
liver/biliary system phenotype J:232077
G0s2tm1Jgte/G0s2tm1Jgte
(involves: 129S7/SvEvBrd)
decreased liver triglyceride level J:219653
decreased liver weight J:219653
decreased susceptibility to hepatic steatosis J:219653
G6pctm1.1Ics/G6pctm1.1Ics
Albtm1(cre/ERT2)Mtz/Alb+

(involves: 129S2/SvPas * C57BL/6J)
abnormal hepatocyte morphology J:195257
enlarged liver J:195257
hepatic steatosis J:195257
increased liver adenoma incidence J:195257
increased liver glycogen level J:195257
increased liver triglyceride level J:195257
increased liver weight J:195257
pale liver J:195257
G6pctm1Jyc/G6pctm1Jyc
(involves: 129S4/SvJae)
enlarged liver J:33212
hepatic necrosis J:33212
hepatic steatosis J:33212
G6pctm2.2Jyc/G6pctm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N)
increased liver weight J:155990
Gab1tm1Wbm/Gab1tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6)
decreased liver weight J:68751
Gab1tm2Wbm/Gab1tm2Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1)
decreased liver weight J:125303
Gab1tm2Wbm/Gab1tm3Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1)
decreased liver weight J:125303
Gab1tm3Wbm/Gab1tm3Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1)
decreased liver weight J:125303
Gaktm2Legr/Gaktm2Legr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * C57BL/6 * DBA)
abnormal bile duct morphology J:180119
abnormal hepatoblast differentiation J:180119
abnormal liver morphology J:180119
decreased liver glycogen level J:180119
jaundice J:180119
Galctwi/Galctwi
Glb1tm1Adz/Glb1+

(involves: 129P2/OlaHsd * C57BL/6J * CE/J)
liver/biliary system phenotype J:63197
Galctwi/Galctwi
Glb1tm1Adz/Glb1tm1Adz

(involves: 129P2/OlaHsd * C57BL/6J * CE/J)
abnormal liver morphology J:63197
enlarged liver J:63197
GaltGt(E285B04)Wrst/GaltGt(E285B04)Wrst
(involves: 129P2/OlaHsd * C57BL/6J)
liver inflammation J:234753
GapdhM6Neu/GapdhM6Neu
(C3.Cg-GapdhM6Neu)
liver/biliary system phenotype J:126359
Gas2l2tm1a(KOMP)Wtsi/Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi)
biliary cyst J:239583
enlarged liver sinusoidal spaces J:239583
Gas2l3tm1d(EUCOMM)Hmgu/Gas2l3tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)
liver/biliary system phenotype J:244087
Gata1Plt13/Y
(BALB/c-Gata1Plt13)
small liver J:113720
Gata1tm1Mym/Y
(involves: 129P2/OlaHsd * BALB/c)
pale liver J:40321
Gata1tm2Sho/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1)
abnormal liver morphology J:78348
Gata1tm2Sho/Gata1tm2Sho
(involves: 129S4/SvJae * C57BL/6 * CD-1)
abnormal liver morphology J:78348
Gata1tm7Sho/Y
(involves: 129S1/Sv * C57BL/6)
liver hypoplasia J:99310
pale liver J:99310
Gata1tm7Sho/Gata1tm7Sho
(involves: 129S1/Sv * C57BL/6)
liver hypoplasia J:99310
pale liver J:99310
Gata1tm8.2Sho/Y
(involves: 129S1/Sv)
liver hypoplasia J:99310
pale liver J:99310
Gata1tm8.2Sho/Gata1tm8.2Sho
(involves: 129S1/Sv)
liver hypoplasia J:99310
pale liver J:99310
Gata2tm1.1Ebres/Gata2tm1.1Ebres
(involves: 129 * BALB/cJ * C57BL/6)
liver hypoplasia J:191756
small liver J:191756
Gata4tm1Eno/Gata4+
Gata6tm1Eno/Gata6+

(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)
small liver J:111824
Gata6tm1Sad/Gata6tm1Sad
(involves: 129S1/Sv * 129X1/SvJ)
abnormal liver bud morphology J:97579
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb)
decreased liver triglyceride level J:191142
decreased susceptibility to hepatic steatosis J:191142
Gbatm1.1Pmis/Gbatm1.1Pmis
Tg(Mx1-cre)1Cgn/0

(involves: C57BL/6 * CBA)
enlarged liver J:167081
increased liver weight J:167081
Gbatm1.1Pmis/Gbatm1.2Pmis
Tg(Mx1-cre)1Cgn/0

(involves: C57BL/6 * CBA)
enlarged liver J:167081
increased liver weight J:167081
Gbatm1Clk/Gbatm1.1Clk
Tg(Tek-cre)12Flv/0

(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6J)
abnormal liver morphology J:117763
Gbatm1Karl/Gbatm1.1Karl
Tg(Mx1-cre)1Cgn/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
enlarged liver J:113751
pale liver J:113751
Gbatm1Rlp/Gbatm1Rlp
(involves: 129S4/SvJae * C57BL/6)
abnormal Kupffer cell morphology J:76409
enlarged liver J:76409
increased hepatocyte apoptosis J:76409
increased liver weight J:76409
liver inflammation J:76409
Gbatm2Ggb/Gbatm1Nsb
(involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6)
abnormal liver physiology J:86334
Gbatm2Ggb/Gbatm2Ggb
(involves: 129S5/SvEvBrd * C57BL/6)
abnormal liver physiology J:86334
Gbatm3Ggb/Gbatm1Nsb
(involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6)
abnormal liver physiology J:86334
Gbatm3Ggb/Gbatm3Ggb
(involves: 129S5/SvEvBrd)
abnormal liver physiology J:86334
Gbatm4Ggb/Gbatm1Nsb
(involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6)
abnormal liver physiology J:86334
Gbatm4Ggb/Gbatm4Ggb
(involves: 129S5/SvEvBrd * C57BL/6)
abnormal liver physiology J:86334
Gbe1m1Yty/Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty)
liver vascular congestion J:167233
Gbe1tm1.1Hoa/Gbe1tm1.1Hoa
(involves: 129S7/SvEvBrd)
decreased liver glycogen level J:176889
Gbe1tm1Hoa/Gbe1tm1Hoa
(involves: 129S7/SvEvBrd)
abnormal liver morphology J:176889
increased liver glycogen level J:176889
Gbe1tm2.1Hoa/Gbe1tm2.1Hoa
(involves: 129S7/SvEvBrd)
increased liver glycogen level J:226481
liver fibrosis J:226481
Gbe1tm2Hoa/Gbe1tm2Hoa
(involves: 129S7/SvEvBrd)
increased liver glycogen level J:226481
Gbvq1CAST/EiJ/Gbvq1CAST/EiJ
(involves: 129S1/SvImJ * CAST/Ei)
dilated gallbladder J:84711
Gcgrtm1.1(KOMP)Vlcg/Gcgrtm1.1(KOMP)Vlcg
(C57BL/6N-Gcgrtm1.1(KOMP)Vlcg/Ucd)
abnormal liver morphology J:211773
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp)
decreased liver weight J:176507
decreased susceptibility to hepatic steatosis J:176507
Gcgrtm1Mjch/Gcgrtm1Mjch
Leprtm1Jke/Leprtm1Jke

(involves: 129 * 129X1/SvJ * C57BL/6J * SJL)
increased liver triglyceride level J:216393
GckRgsc210/GckRgsc210
(involves: C57BL/6J * DBA/2J)
hepatic steatosis J:88919
GckRgsc392/GckRgsc392
(involves: C57BL/6J * DBA/2J)
hepatic steatosis J:88919
GckRgsc702/GckRgsc702
(involves: C57BL/6J * DBA/2J)
hepatic steatosis J:88919
Gcktm1.1Mgn/Gcktm1.1Mgn
Tg(Ins2-cre)25Mgn/0

(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
hepatic steatosis J:51826
Gcktm1.2Mgn/Gck+
(involves: 129S6/SvEvTac * C57BL/6)
hepatic steatosis J:51826
Gcktm1.2Mgn/Gcktm1.2Mgn
(involves: 129S6/SvEvTac * C57BL/6)
hepatic steatosis J:51826
Gcktm1Tka/Gcktm1Tka
(involves: 129X1/SvJ * ICR)
hepatic steatosis J:30334
Gcktm1Ts/Gcktm1Ts
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J))
hepatic steatosis J:29255
Gclctm1Dwn/Gclc+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal liver physiology J:66499
Gclctm1Tdal/Gclctm1Tdal
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * C57BL/6 * DBA)
abnormal liver morphology J:202376
hepatic steatosis J:202376
Gdf1tm1Sjl/Gdf1tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal liver morphology J:60755
Gdf15tm1Sjl/Gdf15tm1Sjl
Leprdb/Leprdb

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BLKS/J)
increased liver weight J:202996
Gfertm1(KOMP)Mbp/Gfer+
(involves: C57BL/6J * C57BL/6N)
abnormal hepatocyte physiology J:224792
decreased hepatocyte proliferation J:224792
decreased liver regeneration J:224792
Gfertm1.1Crg/Gfertm1.1Crg
(involves: 129 * C57BL/6)
abnormal hepatocyte morphology J:227242
Gfertm1.1Crg/Gfertm1.1Crg
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129 * C57BL/6 * DBA)
abnormal liver morphology J:227242
abnormal liver physiology J:227242
abnormal oval cell physiology J:227242
decreased liver cholesterol level J:227242
focal hepatic necrosis J:227242
hepatic necrosis J:227242
hepatic steatosis J:227242
increased hepatocellular carcinoma incidence J:227242
increased hepatocyte apoptosis J:227242
increased hepatocyte proliferation J:227242
increased liver cholesterol level J:227242
increased liver triglyceride level J:227242
increased liver weight J:227242
liver fibrosis J:227242
liver inflammation J:227242
pale liver J:227242
GhSma1/Gh+
(C3HeB/FeJ-GhSma1)
small liver J:89518
GhSma1/GhSma1
(C3HeB/FeJ-GhSma1)
small liver J:89518
Ghrtm1.1Jero/Ghrtm1.1Jero
(B6.129X1-Ghrtm1.1Jero)
decreased liver weight J:155335
Ghrtm1.1Masp/Ghrtm1.1Masp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S4/SvJaeSor * C57BL/6 * DBA)
decreased liver triglyceride level J:152627
hepatic steatosis J:152627
increased liver weight J:152627
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd)
decreased liver weight J:95149
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c)
decreased liver weight J:132437, J:105686, J:60207
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
decreased liver weight J:107763
Ghrtm2Mwat/Ghrtm2Mwat
(involves: 129X1/SvJ * C57BL)
decreased liver weight J:95149
Ghrhtm1Salv/Ghrhtm1Salv
(involves: 129 * C57BL/6)
abnormal liver physiology J:91828
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J)
abnormal liver morphology J:160090
liver/biliary system phenotype J:160090
Gimap5m1Btlr/Gimap5m1Btlr
(either: (involves: BALB/cJ * C57BL/6J) or (involves: C3H/HeN * C57BL/6J) or (C57BL/6J * DBA/2J) or (involves: C57BL/6J * FVB/NJ) or (involves: C57BL/6J * NOD/ShiLtJ))
abnormal liver morphology J:160090
Gimap5tm1Wlr/Gimap5tm1Wlr
(either: B6.129-Gimap5tm1Wlr or C.129-Gimap5tm1Wlr)
abnormal liver development J:143620
abnormal liver parenchyma morphology J:143620
hepatic necrosis J:143620
liver degeneration J:143620
liver/biliary system phenotype J:143620
pale liver J:143620
Gjb1tm1Kwi/Y
(involves: 129S4/SvJae * C57BL/6)
abnormal liver physiology J:36146
increased liver glycogen level J:36146
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129S4/SvJae * C57BL/6)
abnormal liver morphology J:36146
Gjb4tm1.1(KOMP)Vlcg/Gjb4tm1.1(KOMP)Vlcg
(C57BL/6N-Gjb4tm1.1(KOMP)Vlcg/Ucd)
abnormal liver morphology J:211773
Gktm1Wjc/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
hepatic steatosis J:43449
Glatm1Kul/Y
(involves: 129S4/SvJae * C57BL/6)
abnormal liver morphology J:39394
Glb1tm1Jmat/Glb1tm1Jmat
(involves: C57BL/6 * CBA * ICR)
abnormal hepatocyte morphology J:102576
small liver J:43534
GlmpGt(P084H04)Wrst/GlmpGt(P084H04)Wrst
(involves: 129S2/SvPas * C57BL/6)
abnormal hepatocyte physiology J:208774
abnormal Kupffer cell morphology J:208774
abnormal liver physiology J:208774
increased hepatocyte apoptosis J:208774
increased liver iron level J:208774
liver fibrosis J:208774
liver inflammation J:208774
Glmptm1Lex/Glmptm1Lex
(B6;129S5-Glmptm1Lex/Mmucd)
liver inflammation J:171883
small liver J:171883
Glultm1.1Geno/Glultm1.1Geno
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * C57BL/6J * DBA)
liver/biliary system phenotype J:221031
Gm572b2b1167Clo/Gm572b2b1167Clo
(C57BL/6J-Gm572b2b1167Clo)
abnormal liver morphology J:175213
Gna11tm1Soff/Gna11tm1Soff
(involves: 129S7/SvEvBrd)
hepatic steatosis J:172091
increased liver triglyceride level J:172091
Gnai2tm1Lbi/Gnai2+
Tg(WTbeta2)4Wjk/0

(B6.Cg-Gnai2tm1Lbi Tg(WTbeta2)4Wjk)
abnormal liver morphology J:125581
Gnastm5Lsw/Gnastm5Lsw
Tg(Alb1-cre)1Dlr/?

(involves: 129S6/SvEvTac * Black Swiss * FVB/N)
increased liver weight J:102504
Gnastm5Lsw/Gnastm5Lsw
Tg(Fabp4-cre)1Abel/0

(involves: FVB)
decreased liver triglyceride level J:159612
Gnf4C57BL/6J/?
(involves: M16i * M16i.B6-(D2Mit306-D2Mit52))
decreased liver weight J:99312
Gnmttm1Ymac/Gnmt+
(involves: 129/Sv * C57BL/6)
decreased liver weight J:147857
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6)
abnormal liver morphology J:147857
enlarged liver J:147857
enlarged liver sinusoidal spaces J:147857
hepatic necrosis J:147857
hepatic steatosis J:146081
increased hepatic hemangioma incidence J:146081
increased hepatocellular carcinoma incidence J:146081
increased liver glycogen level J:147857
increased liver weight J:147857
liver degeneration J:147857
Golga2tm1(KOMP)Vlcg/Golga2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
abnormal hepatocyte morphology J:270564
abnormal liver morphology J:270564
liver fibrosis J:270564
Golm1Gt(KST273)Byg/Golm1Gt(KST273)Byg
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hepatocyte morphology J:151282
hepatic steatosis J:151282
liver inflammation J:151282
Gpamtm1.1Dali/Gpamtm1.1Dali
(involves: 129S1/Sv * 129X1/SvJ)
abnormal hepatocyte morphology J:134068
abnormal liver physiology J:134068
decreased liver triglyceride level J:134068
Gpamtm1Rcol/Gpamtm1Rcol
(involves: 129S6/SvEvTac * C57BL/6J)
decreased liver triglyceride level J:84541
Gpat3tm1Reg/Gpat3tm1Reg
(involves: C57BL/6)
increased liver cholesterol level J:213618
increased liver weight J:213618
Gpbar1tm1Gvas/Gpbar1tm1Gvas
(involves: 129S1/SvImJ * C57BL/6)
abnormal bile composition J:115877
abnormal bile duct development J:115877
abnormal gallbladder morphology J:115877
gallstones J:115877
liver/biliary system phenotype J:115877
Gpd2tm1Tka/Gpd2tm1Tka
Slc25a13tm1Lct/Slc25a13tm1Lct

(B6.Cg-Gpd2tm1Tka Slc25a13tm1Lct)
hepatic steatosis J:124766
increased liver triglyceride level J:124766
Gper1tm1135.2Arte/Gper1tm1135.2Arte
(involves: C57BL/6 * C57BL/6N)
decreased liver weight J:145794
Gpi1b-m1Neu/Gpi1b-m1Neu
(C3.Cg-Gpi1b-m1Neu)
increased liver weight J:35956
Gpi1b-m2Neu/Gpi1b-m2Neu
(C3.Cg-Gpi1b-m2Neu)
increased liver weight J:35956
Gpr12tm1Dgen/Gpr12tm1Dgen
(B6.129P2-Gpr12tm1Dgen)
increased liver triglyceride level J:111942
increased liver weight J:111942
Gpr132tm1Witt/Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c)
liver inflammation J:69473
Gprc5btm1b(EUCOMM)Wtsi/Gprc5btm1b(EUCOMM)Wtsi
(C57BL/6N-Gprc5btm1b(EUCOMM)Wtsi/Ucd)
abnormal liver morphology J:211773
Gprc6atm1Ldq/Gprc6atm1Ldq
(involves: 129X1/SvJ * C57BL/6)
hepatic steatosis J:144372
increased liver triglyceride level J:144372
Gps1tm1b(KOMP)Wtsi/Gps1+
(C57BL/6N-Gps1tm1b(KOMP)Wtsi/Tcp)
abnormal liver size J:211773
Gpx4tm1.1Qra/Gpx4tm1.1Qra
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+

(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * SJL)
increased hepatocyte apoptosis J:183246
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6)
hepatic steatosis J:193993
Grb10Gt(Betageo)1Ward/Grb10+
(involves: C57BL/6 * CBA)
enlarged liver J:84425
increased liver glycogen level J:84425
Grb10Gt(Betageo)1Ward/Grb10Gt(Betageo)1Ward
(involves: C57BL/6 * CBA)
enlarged liver J:84425
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Adipoq-cre)#Pesch/0

(involves: 129S/SvEv * FVB)
hepatic steatosis J:213603
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Fabp4-cre)1Rev/0

(involves: 129S/SvEv)
hepatic steatosis J:213603
Grb14tm1Daly/Grb14tm1Daly
(involves: 129X1/SvJ * C57BL/6)
decreased liver weight J:87892
Greb1lem1Cjea/Greb1lem1Cjea
(involves: C57BL/6J)
liver hypoplasia J:248902
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6J)
increased liver weight J:268827
Grntm1.1Geno/Grntm1.1Geno
(involves: 129 * C57BL/6J)
abnormal hepatocyte morphology J:188420
abnormal hepatocyte physiology J:188420
abnormal liver morphology J:188420
abnormal liver parenchyma morphology J:188420
increased hepatocyte karyomegaly J:188420
Gsk3atm1.1Jrw/Gsk3atm1.1Jrw
(involves: 129S6/SvEvTac * C57BL/6)
increased liver glycogen level J:130033
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
increased liver glycogen level J:98263
Gsk3btm1Jrw/Gsk3btm1Jrw
(involves: 129 * C57BL/6J)
abnormal hepatocyte morphology J:63274
abnormal liver morphology J:63274
Gstz1tm1Jmfc/Gstz1tm1Jmfc
(129S4/SvJae-Gstz1tm1Jmfc)
abnormal liver morphology J:77040
hepatic necrosis J:77040
hepatic steatosis J:77040
Gstz1tm1Pgb/Gstz1tm1Pgb
(BALB/c-Gstz1tm1Pgb/AnuApb)
abnormal hepatocyte morphology J:91519
hepatic necrosis J:91519
hepatic steatosis J:91519
increased liver weight J:91519
liver inflammation J:91519
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sortm1(cre/ERT2)Tyj
Nus1tm1.1Qrm/Nus1tm1.1Qrm

(involves: 129 * C57BL/6 * SJL)
hepatic steatosis J:243753
increased liver free fatty acids level J:243753
increased liver triglyceride level J:243753
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
Chrna7tm2.1(cre)Swr/Chrna7+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
enlarged liver J:223063
Gt(ROSA)26Sortm1(DTA)Riet/Gt(ROSA)26Sor+
Tg(Alb1-cre)7Gsc/0

(involves: 129P2/OlaHsd)
liver degeneration J:92789
Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/?

(involves: 129S1/Sv * C57BL/6 * CBA)
enlarged liver J:129039
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu

(involves: 129P2/OlaHsd * 129X1/SvJ)
enlarged liver J:167612
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+
Tg(Gh1-cre)bKnmn/0

(involves: C57BL/6 * FVB/N)
decreased liver triglyceride level J:169459
decreased liver weight J:169459
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Tg(Adipoq-cre)1Evdr/0

(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ)
hepatic steatosis J:237232
increased liver weight J:237232
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(CAG-cre)1Nagy/0
Tg(tetO-Vegfa)90Ala/0

(involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)
hepatic peliosis J:99607
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc3)12740Njen/0

(involves: C3H * C57BL/6J)
increased hepatocellular carcinoma incidence J:153656
increased liver adenoma incidence J:153656
increased liver tumor incidence J:153656
Gt(ROSA)26Sortm1(Tfrc*)Nca/Gt(ROSA)26Sor+
Hfetm2Nca/Hfetm2Nca

(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N)
increased liver iron level J:133221
Gt(ROSA)26Sortm1(Tfrc*)Nca/Gt(ROSA)26Sortm1(Tfrc*)Nca
(involves: 129S4/SvJae * FVB/N)
increased liver iron level J:133221
Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/Gt(ROSA)26Sor+
Tg(Nes-cre)1Wmz/0

(involves: 129 * C57BL/6 * FVB/N * SJL/J)
enlarged liver J:185598
Gt(ROSA)26Sortm1.1(Aco1*)Mwh/Gt(ROSA)26Sortm1.1(Aco1*)Mwh
(B6.129P2(129S1)-Gt(ROSA)26Sortm1.1(Aco1*)Mwh)
increased liver iron level J:196374
Gt(ROSA)26Sortm1.1(CAG-Upp1,-GFP)Gp/Gt(ROSA)26Sor+
(involves: C57BL/6 * FVB/N)
hepatic steatosis J:195165
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(MMTV-cre)4Mam/0

(involves: C57BL/6J * C57BL/6N * FVB/N)
enlarged liver J:202090
liver inflammation J:202090
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0

(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
enlarged liver J:202090
liver inflammation J:202090
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0

(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
abnormal liver morphology J:207306
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Lck-cre)I57Jxm/0

(involves: 129S6/SvEvTac * ICR)
abnormal liver morphology J:207306
Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+

(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
enlarged liver J:137122
Gt(ROSA)26Sortm2(OVA/EGFP)Dwir/Gt(ROSA)26Sor+
Albtm1(cre/ERT2)Mtz/Alb+

(involves: 129P2/OlaHsd * 129S2/SvPas)
abnormal hepatocyte physiology J:173806
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
TgTn(sb-T2/Onc)68Dla/0

(involves: C57BL/6 * DBA/2 * FVB/N)
abnormal liver morphology J:147264
increased hepatocellular carcinoma incidence J:147264
increased liver adenoma incidence J:147264
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0

(involves: 129 * C57BL/6 * C57BL/6J)
liver cirrhosis J:153656
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Trp53tm3Tyj/Trp53+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
TgTn(sb-T2/Onc)68Dla/0

(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
abnormal liver morphology J:147264
increased hepatocellular carcinoma incidence J:147264
increased liver adenoma incidence J:147264
Gt(ROSA)26Sortm2Bet/Gt(ROSA)26Sortm2Bet
Speer6-ps1Tg(Alb-cre)21Mgn/?

(involves: BALB/c * C57BL/6 * DBA)
abnormal bile duct development J:174261
abnormal bile duct morphology J:174261
abnormal intrahepatic bile duct morphology J:174261
abnormal liver morphology J:174261
decreased hepatocyte number J:174261
increased hepatocyte proliferation J:174261
increased liver weight J:174261
Gt(ROSA)26Sortm3(HIF1A*)Kael/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
abnormal hepatocyte morphology J:144666
hepatic steatosis J:144666
Gt(ROSA)26Sortm3(HIF1A*)Kael/Gt(ROSA)26Sortm4(HIF2A*)Kael
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
abnormal liver morphology J:144666
hepatic steatosis J:144666
increased hepatocyte proliferation J:144666
increased liver weight J:144666
Gt(ROSA)26Sortm4(CAG-hsb5)Nki/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
Tg(Tal1-tTA)19Dgt/0
Tg(tetO-BCR/ABL1)2Dgt/0
TgTn(pb-sb-GrOnc)#aGsva/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA/J * DBA/2 * FVB/N)
increased liver weight J:227558
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
abnormal liver morphology J:144666
hepatic steatosis J:144666
increased hepatocyte proliferation J:144666
increased liver weight J:144666
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+
Tg(Myh6-cre)2182Mds/0

(involves: 129S6/SvEvTac * FVB/N)
liver vascular congestion J:179490
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sor+
Tg(CAG-cre/Esr1*)5Amc/0

(B6.Cg-Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky Tg(CAG-cre/Esr1*)5Amc)
hepatic steatosis J:264410
liver hemorrhage J:264410
Gt(ROSA)26Sortm9(cre/ESR1)Arte/?
Tnfaip3tm1Homy/Tnfaip3tm1Homy

(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
abnormal liver morphology J:212681
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+

(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ)
enlarged liver J:181546
Gt(ROSA)26Sortm11(Lmp1